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 With an impact on nearly 1 billion individuals worldwide and 70 million Americans 
currently, hypertension is one of the most readily identifiable risk factors for myocardial infarction 
(MI), heart failure, stroke, aortic aneurysms, dissections, and peripheral vascular disease. 
Furthermore, with rapidly aging populations around the world and ever increasing obesity rates, 
the burden of hypertension is estimated to affect a staggering 1.5 billion individuals globally by 
the year 2025  [1].  Hypertension is known to accelerate vascular inflammation – a hallmark of 
several cardiovascular disease pathologies – although the exact mechanism by which this happens 
still remains largely unknown. 
The primary objective of this thesis was, therefore, to (a) explore the mechanisms by which 
elevated cyclic strain in the setting of hypertension leads to inflammation of the aorta and (b) to 
better identify the role of the potent pro-inflammatory protein osteopontin (OPN) and its role in 
regulating vascular inflammation and remodeling.  We hypothesized that (a) elevated cyclic 
vascular wall strain acts through ROS to increase the expression of OPN and that (b) this increased 
OPN expression leads to a decrease in aortic compliance in the setting of hypertension. We used a 
cell culture (in-vitro) approach, two reproducible murine (in-vivo) models of hypertension, and 
performed mechanical testing of isolated murine aortas (ex-vivo) to test these hypotheses.  
We found that OPN is upregulated with cyclic strain in culture smooth muscle cells and in 
the aortas of hypertensive mice. We have further identified that cyclic strain increases levels of 
ROS like superoxide (O2
•-) and hydrogen peroxide (H2O2) in vascular smooth muscle cells. We 
also observed that transgenic mice that overexpress human catalase (a H2O2 scavenger), 
specifically in their smooth muscle cells (TgSMC-Cat) are protected against an increase in the 
expression of hypertension-induced OPN. These observations strongly suggest a prominent role 
 
 xix 
of ROS, in mediating the translation of mechanical cues such as elevated vascular wall strain in 
the setting of hypertension, into increased expression of pro-inflammatory products such as OPN. 
Our in-vitro findings also suggest a potential role for NADPH oxidases (which are major sources 
of ROS), in mediating mechanical strain-induced OPN production. In conclusion, these in-vitro 
and in-vivo studies suggest that elevated mechanical strain in the setting of hypertension may have 
an independent effect on upregulating critical mediators of inflammation, in our case OPN, and 
that this increase is regulated via ROS such as H2O2. 
Finally, we have observed that OPN plays a role in mediating the mechanical properties of 
the aorta. Our ex-vivo mechanical tests have revealed that OPN KO aortas have increased pressure-
dependent diameters under both baseline and hypertensive conditions as compared to their WT 
counterparts. 
In conclusion, this thesis shows that (1) the arterial wall is sensitive to changes in its 
mechanical environment, and that (2) it responds to these mechanical changes via ROS dependent 
pathways by (3) increasing expression of pro-inflammatory proteins like OPN which (4) ultimately 
leads to vascular remodeling and inflammation. Overall these results deepen our understanding of 
the underlying mechanisms leading to vascular inflammation, and could have significant 







Hypertension is a multifactorial inflammatory disease that imparts a myriad of humoral 
and mechanical signals to the vascular wall [2, 3]. Humoral signals are complex and variable. The 
renin-angiotensin system, comprised of molecules such as angiotensin-II (AngII), is one example 
of a humoral mechanism [3]. Mechanical stimuli impacting the arterial wall in-vivo are 
simplistically divided into three components – 1) frictional wall shear stress caused by flow across 
the endothelial layer, 2) circumferential and axial stress by wall deformation due to pulsatile blood 
flow and longitudinal tractions respectively, and finally 3) compressive stress due to the 
hydrostatic pressure of blood [4].  
While the specific role and relative importance of humoral and mechanical signals in the 
ultimate development of vascular pathologies is not completely understood, a growing body of 
evidence has established that a combination of these signals leads to vascular inflammation [2]. 
This process involves accumulation of cells such as macrophages and leukocytes in the arterial 
wall [3]. Studies from many other labs and our own suggest that increased reactive oxygen species 
(ROS), such as superoxide (O2
•-) and hydrogen peroxide (H2O2), play a vital role in modulating 
the inflammatory response in hypertension by stimulating increased pro-inflammatory gene 
products [3, 5]. 
It has been shown that vascular inflammation is mediated by a plethora of pro-
inflammatory gene products including osteopontin (OPN). Evidence from our lab has suggested 
that OPN plays a role in mediating AngII induced vascular hypertrophy [6] and that OPN is 
regulated by H2O2 [7]. 
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While several studies suggest a potential causal link between elevated mechanical cyclic 
strain in the setting of hypertension and pro-inflammatory proteins, very few have actually proven 
that such a relationship in fact exists. We, therefore, hypothesized that mechanical changes due to 
hypertension increase ROS, which in turn enhance OPN expression, and that this ultimately leads 
to altered blood vessel biomechanics.  
SPECIFIC AIM 1 
Establish if mechanical stretch in-vitro increases osteopontin expression 
Our first objective was to determine if mechanical strain applied to isolated vascular 
smooth muscle cells (SMCs) in culture would induce an increase in OPN expression and to 
determine if this increase was ROS dependent. We used a computer controlled bioreactor that 
applied uniform, reproducible biaxial strain to SMCs. Following treatment, the media surrounding 
these SMCs and the cells themselves were harvested and analyzed for H2O2, protein, and mRNA 
levels using molecular techniques including amplex red assay, Western Blotting, ELISA, and 
quantitative real time PCR (qRT-PCR). We hypothesized that mechanical strain of SMCs would 
induce a H2O2-dependent increase of OPN expression. 
SPECIFIC AIM 2 
To determine if osteopontin expression is increased in a murine model of hypertension and if this 
increase is H2O2-dependent  
In this aim, we assessed the role of H2O2 in the regulation of OPN in-vivo using two murine 
models of hypertension. The reason why we utilized two independent murine models of 
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hypertension by infusing two humoral agents, namely, AngII and norepinephrine (NE), was in 
order to delineate the effects of humoral versus mechanical factors.  We also used a strain of 
transgenic mice that specifically overexpresses catalase in smooth muscle to determine if H2O2 is 
responsible for modulating OPN expression in hypertension. Following treatment, murine aortas 
were harvested and analyzed for OPN mRNA and protein levels using qRT-PCR, 
immunohistochemistry, and Western Blotting. We hypothesized that hypertension would increase 
OPN expression in the murine aorta, via a H2O2-dependent pathway. 
SPECIFIC AIM 3 
To determine the contribution of osteopontin to the mechanical properties of the aorta at 
baseline and in the setting of hypertension. 
In this aim, differences in the biomechanical properties of the aorta in OPN knock-out (KO) 
mice and wild type (WT) mice - under baseline and hypertensive conditions - were studied. Murine 
aortas were excised, cleaned of excess fat, and loaded onto a vessel isolation chamber and 
transmural pressures within the aorta was varied at fixed intervals. The outer diameter of the aorta 
was continuously recorded. Pressure-diameter curves, local compliance, and histology of the aorta 
was analyzed for the different groups that ultimately shed light on differences in vessel mechanical 
properties due to the presence or absence of OPN. OPN is believed to mediate vascular 
hypertrophy in the setting of hypertension, leading to aortic stiffness, and therefore, we 
hypothesized that hypertensive OPN KO mice would have more compliant aortas compared to 




Significance and Innovation 
Hypertension is one of the leading risk factors for cardiovascular morbidity and mortality 
[8]. Nearly one third (~29%) of all US adults over the age of 18 are hypertensive [9]. However, 
hypertension is not a single disease entity, but rather a clinical presentation of different underlying 
diseases that leads to elevated blood pressure [4]. With this premise in mind, it is surprising that 
these varied etiologies cause a uniform response on the arterial wall which includes thickening of 
the vessel wall (hypertrophy) and early atherosclerotic lesions [3]. A possible explanation for this 
uniform effect may be attributed to the common stimulus in hypertension – which is the increased 
mechanical strain on the arterial wall as a result of elevated blood pressure. While several studies 
have explored the role of humoral signals on the vascular wall, very few have studied the effects 
of mechanical stimuli on smooth muscle cells. 
 Moreover, the effects of hypertension on the vascular wall are so varied and numerous that 
its pathological consequences affect almost every single organ system, especially the 
cardiovascular system. Therefore, it is imperative to fully understand the effects of hypertension 
on large arteries. The results of this study will allow us to understand whether the increase in pro-
inflammatory protein, osteopontin (OPN), under hypertensive conditions is modulated by ROS 
and for the first time, we will also be able to determine the role OPN plays in modulating the 





BACKGROUND AND LITERATURE REVIEW 
 
Blood Vessels of the Human Body – Arteries and Veins 
The cardiovascular system (CVS) comprises of the heart and blood vessels that are 
responsible for the transportation of blood. This is essential for the delivery of vital nutrients and 
hormones, and removal of waste products to and from different organs, tissues, and cells of the 
body [10]. Arteries and veins are the two major types of blood vessels of the CVS. Arteries are 
thick-walled, elastic, muscular conduits whose main function is to transport oxygenated blood 
from the heart to the rest of the body, while veins collect deoxygenated blood from all the tissues 
and organs of the body, and transports it back to the heart, which then pumps it to the lungs for 
oxygenation [10].  
Aorta: Structure, Function, and Mechanics 
 The aorta is the largest artery of the body, running from the aortic valve to the iliac 
bifurcation [11]. Its most important function is to distribute oxygenated blood from the heart to the 
rest of the body and to convert the intermittent inflow of blood it receives during systole, into a 
steady outflow at the smaller arteries and capillaries, during diastole – also referred to as the 
Windkessel effect [11, 12].  
The aorta comprises of three main layers broadly classified as the (a) intima, (b) media, 
and (c) adventitia (Fig 2.1). The intima is the innermost layer of the aorta which is lined by a single 
cell layer of endothelial cells, serving as the primary interface with flowing blood. The media is 
the middle layer of the aorta comprising of smooth muscle cells and elastic fibers that allows for 
the contraction and expansion of aorta with each heartbeat. The media is the thickest layer of the 
aorta comprising around 80% of the thickness [11].  The adventitia is the outermost layer of the 
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aorta and consists mostly of collagen and a network of blood vessels called the vasa vasorum that 
nourishes the outer half of the aorta [11]. 
 
Figure 2.1: Layers of the Healthy Aorta The aorta comprises of three main layers – the intima, 
media, and adventitia. The intima comprises of a single layer of endothelial cells that is exposed 
to a shear stress from flowing blood, the media comprises of alternating layers of vascular smooth 
muscle cells, elastin, and collagen. The outer adventitial layer comprises of collagen and fibroblast 
cells. 
  
There are numerous structural proteins and cell types that support the function of the aorta 
that include collagen and elastic fibers, endothelial cells, and smooth muscle cells (SMCs) as 
previously mentioned [13]. These structural proteins and cell types are normally under tension as 
reflected by the contraction of the aortic diameter by 20% and length by 40% when it is isolated 
from the body [14]. The pressure due to blood further induces a strain within the aorta, ranging 
from around 10% to 20% [15].  
The aorta is constantly exposed to several mechanical forces due to blood flow and the 
pressure generated by the heart with every heartbeat. The major forces acting on the aorta include 
(a) wall shear stress which is primarily experienced by the intimal endothelial layer due to the 
parallel flow of blood (b) circumferential stress generated from blood flow during the systolic and 
diastolic phases of the beating heart, and finally (c) compressive forces due to the hydrostatic 




 Hypertension or high blood pressure is defined as the state wherein the mean systolic blood 
pressure is higher than 140 mmHg and mean diastolic blood pressure is higher than 90mm Hg [9, 
17, 18]. Hypertension was the primary or leading cause of death in about 360,000 Americans in 
2008 or an estimated 1000 deaths per day [9].  
About 30% of the US population aged 18 to 65 suffers from hypertension – that’s a total 
of about 70 million individuals or about 1 in every 3 adults [9]. Furthermore, another 29% of US 
adults are pre-hypertensive – which is defined as a systolic blood pressure ranging from 120-139 
mmHg or 80-89 mmHg of diastolic blood pressure – which further increases their risk of 
developing hypertension [9]. It is also discouraging to note that roughly only 52% of hypertensive 
patients have their blood pressure under control [9]. 
The prevalence of hypertension increases with age to more than 50% in the population 
aged 60 to 69, and to 70% in populations aged 70 years or older [17]. It is also important to note 
differences in the prevalence of hypertension among different population groups. The prevalence 
is much higher in the non-Hispanic black population (42.1%) than in the non-Hispanic White 
(28%), non-Hispanic Asian (24.7%), or Hispanic populations (26%) [17, 19]. Hypertension is also 
slightly more prevalent among men (29.7%) than women (28.5%) [19].  
 There is a very strong correlation between the incidence of hypertension and the risk of 
developing coronary heart disease (CHD) and stroke [17]. Furthermore, hypertension is a leading 
predictor for the development of end-stage kidney and heart failure [17]. Overall, hypertension 
poses a major global public health challenge and therefore, a deeper understanding of its etiology, 
progression, and myriad consequences are imperative to reduce hypertension associated morbidity 




 Systemic blood pressure is quantitatively defined as the product of peripheral resistance 
and cardiac output (Fig 2.2) [20]. Peripheral resistance is often almost entirely dependent on the 
properties of small arteries whose diameters are less than 1mm [20], however, the compliance 
properties of large arteries such as the aorta also affects blood pressure, especially in the systolic 
phase, and particularly in the older population [20]. When either quantity - peripheral resistance 
or cardiac output - systemically increases, this results in high blood pressure. Humoral factors 
including AngII and NE also have significant impacts on the regulation of blood pressure in the 
body, by controlling vasoconstriction of arteries and thereby increasing blood pressure, when 
released. 
 
Figure 2.2: Definition and Factors Influencing Blood Pressure Systemic blood pressure is 
defined as the product of peripheral resistance and cardiac output. There are several factors such 
as blood viscosity and heart rate that modulate blood pressure by affecting peripheral resistance 
and cardiac output. Adapted from [20]. 
  
 The two major factors that predispose individuals towards hypertension, by having a direct 
effect on peripheral resistance or cardiac output, are (a) genetics and (b) a plethora of demographic 
and environmental factors [17]. Some of the most notable demographic and environmental factors 
include (a) diets that are high in sodium and low in potassium and calcium, (b) a high intake of 
alcohol and tobacco, (c) elevated stress, (d) lack of exercise, (e) socioeconomic status, and (f) 
aging [20]. 
SYSTEMIC BLOOD PRESSURE (BP) =  
PERIPHERAL RESISTANCE (PR) X CARDIAC OUTPUT (CO) 
 
 
Blood viscosity                                          Heart Rate 
   Artery length                                       Stroke Volume 




A major consequence of elevated blood pressure is the onset of vascular inflammation 
within and around the tissues surrounding arteries such as the aorta [3, 21], and it is recognized as 
one of the most critical processes leading to the development of several other cardiovascular 
disease pathologies such as atherosclerosis [2], abdominal aortic aneurysms [22], dissections [23], 
strokes [24, 25], myocardial ischemia [25], and infarction [25]. Several clinical studies have 
highlighted a direct correlation between increasing blood pressure and plasma levels of 
inflammatory and adhesion markers such as C-reactive protein (CRP), interleukin-6 (IL-6), 
vascular cell adhesion molecule (VCAM-1), platelet endothelial cell adhesion molecule 
(PECAM), and intercellular cell adhesion molecule (ICAM-1) [26-29]. Anti-fibrinolytic proteins 
such as plasminogen activator protein (PAI-1) and chemokines such as monocyte chemoattractant 
factor (MCP-1) have also been shown to be upregulated with hypertension. Finally, transcription 
factors that mediate levels of the aforementioned inflammatory proteins, such as nuclear factor-
B (NF-B) and activator protein-1 (AP-1) have been shown to increase within vascular tissue 
obtained from hypertensive animals [30, 31]. 
 
Effects of Hypertension on the Aorta 
The healthy aortic wall is a carefully regulated and balanced, but dynamic system, 
constantly interacting with a plethora of local and global environmental cues. On the one hand it 
is exposed to several humoral stimuli such as growth factors, contractile agonists, and 
differentiation factors; while on the other, it is constantly stimulated by mechanical forces that 
include active stresses and strains, hemodynamic forces, and passive stretch [32, 33]. With the 
onset of hypertension, there is an imbalance in these forces – the most prominent being a uniform 
increase in circumferential strain as a result of elevated blood pressure applied on the aortic wall. 
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The cells of the aorta are thus primed to adapt to this elevated strain, leading ultimately to adaptive 
or maladaptive responses. Adaptive responses lead to vascular hypertrophy and normalization of 
arterial wall stress [3, 4], while maladaptive responses lead to changes in the vascular wall that 
directly or indirectly cause secondary vascular pathologies, such as atherosclerosis, dissections, 
and aneurysms [22, 23, 34, 35] 
Currently there is considerable debate over the specific role and relative importance of the 
numerous humoral and mechanical stimuli in the progression of these adaptive or maladaptive 
changes in response to hypertension. In reality, the net effect of hypertension is likely a “synthesis 
of multiple input stimuli from both categories” – humoral and mechanical [4]. There is, however, 
a definite need for future studies to further elucidate the specific mechanisms that control 
hypertension related vascular inflammation and clearer identification of potential therapeutic 
targets.   
 
Humoral Effects of Hypertension: 
Renin-Angiotensin-Aldosterone System (RAAS) and Norepinephrine (NE) 
 The renin-angiotensin-aldosterone (RAAS) system is a critical modulator of blood pressure 
in the body (Fig 2.3). The juxtaglomerular cells of the kidney synthesize and release the enzyme 
renin, which catalyzes the conversion of angiotensinogen into angiotensin-I (AngI) [36, 37]. The 
final step of this pathway is the conversion of angiotensin-I (AngI) into angiotensin-II (AngII) in 
the presence of angiotensin converting enzyme (ACE) and other proteases such as chymase [38].  
The most important physiologic and pathophysiologic outcomes of the RAAS pathway are in fact 
regulated by AngII. These AngII mediated processes range from vasoconstriction of arteries, 
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aldosterone production and release, sodium reabsorption, stimulation of thirst, and a heightened 
sympathetic response [20]. 
 
 
Figure 2.3: Renin-Angiotensin-Aldosterone (RAAS) Pathway AngII is the final product of the 
Renin-Angiotensin-Aldosterone pathway that plays a critical role in the regulation of blood 
pressure in the body and is typically upregulated at the onset of hypertension. 
  
In the setting of hypertension, AngII plays a potent role in mediating pathophysiologic 
vascular change by modulating cytokine production and oxidative stress, which in turn leads to 
adhesion molecule expression, vascular wall inflammation, extracellular matrix (ECM) deposition, 
hypertrophy, and proliferation of vascular smooth muscle cells (SMCs) [39-42]. AngII, in the 
context of hypertension, is also a potent stimulator of PAI-1 and activator of matrix 
metalloproteinases (MMPs) which may promote plaque rupture and a pro-thrombotic environment 
within an atherosclerotic lesion [43, 44]. Finally, AngII activates the enzyme nicotinamide adenine 
dinucleotide phosphate oxidase (NADPH oxidase) which is a major source of reactive oxygen 
species (ROS) such as superoxide (O2
•-) and hydrogen peroxide (H2O2) [39, 45]. In the healthy 
aorta, these ROS act as important second messengers in vascular smooth muscle cells and in 
modulating vascular tone and structure [39, 46], but with hypertension these ROS induce vascular 








(SMCs) and collagen deposition [21, 47, 48]. AngII further stimulates the expression of adhesion 
proteins such as ICAM-1 and MCP-1 through the activation of NADPH oxidases, which in turn 
attract a host of inflammatory cells such as macrophages which leads to a pro-inflammatory 
environment conducive to vascular injury and dysfunction [49].  
Aldosterone is a byproduct of the RAAS pathway that is synthesized in the zona 
glomerulosa of the adrenal cortex [50]. It is a steroid hormone that regulates salt and water balance 
in the body, by promoting unidirectional sodium transport and consequentially the retention of 
water [51]. Animal studies have shown that a diet high in sodium in the presence of excess 
aldosterone causes organ damage characterized by perivascular inflammation and necrosis [52].  
Norepinephrine (NE) is a catecholamine or stress hormone that has a direct effect on blood 
pressure [53]. It is part of the sympathetic nervous system. Some of its most profound effects 
include (a) rapid increase in blood pressure (b) shunting blood towards the skeletal muscle system, 
heart, and brain, and away from the gastrointestinal system (c) increase of heart rate and 
contraction (d) elevated respiration and bronchodilation (e) increased lipid breakdown in 
adipocytes (f) and increased production of glucose and glycolysis in the liver [53]. Typically, the 
presence of NE is necessary in the short term for an individual’s survival. However, elevated levels 
of this circulating catecholamine over long periods of time may lead to development of 
pathological conditions that range from cardiac hypertrophy, hypertension, and post-traumatic 
stress disorder (PTSD) [53]. Catecholamines can further induce cell proliferation on vascular 






Mechanical Effects: Arterial Remodeling 
Understanding the mechanical effects of hypertension on large arteries has become a 
critical area of investigation in cardiovascular research and biomechanics, especially since it is 
known that large arteries associated with hypertension have a tendency to develop early 
atherosclerotic lesions, aneurysms, and dissections [55]. Some of the well recorded effects of 
hypertension on arteries include vascular hypertrophy [47] and decreased arterial compliance (Fig 
2.4) [55].  
Early studies by Burton et al. have highlighted that increasing luminal pressure within 
arteries causes an increase in arterial radius, which then leads to increased arterial wall tension 
[56]. The effect of acutely elevated vascular wall tension with hypertension would then lead to 
vascular hypertrophy, increased wall thickness, and therefore reduced wall stress [3, 4, 41, 56]. 
Other modeling and observational studies have also shown that increased pulsatile arterial pressure 
induces wall stress at certain sites along the aorta (such as bifurcations), which in addition to a 
high fat diet leads to development of atherosclerotic lesions at these locations [34]. 
Another study looking into the direct effects of mechanical pressure on the aortic wall was 
conducted by Ollerenshaw et al, where an aortic coarctation model of hypertension was used and 
demonstrated the presence of significantly higher vascular hypertrophy in the region above the 
coarctation, where the blood pressure was elevated, as opposed to the region below the coarctation, 
where blood pressure was normal [57]. This study further highlighted that even though the region 
above and below the coarctation was exposed to the same humoral milieu; the differences in 
mechanical pressure seemed to have a greater effect on vascular hypertrophy [57]. However, there 
is still a significant need for future studies to highlight the role of mechanical forces within the 
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blood vessel and better elucidate how they contribute to the progression and development of 







Figure 2.4: Differences in Aortic Compliance with Age & Disease The healthy aorta is typically 
compliant among younger age groups, but stiffens with age. This stiffness maybe attributed to 




Reactive Oxygen Species: Overview 
 ROS are oxygen-based molecules and sometimes contain an unpaired free electron. The 
summed effect of these ROS in living systems is commonly referred to as oxidative stress. The 
most important ROS in the vasculature include superoxide (O2
•-), nitric oxide (NO•), peroxynitrite 
(ONOO•-), and hydrogen peroxide (H2O2), which play important roles as signaling molecules that 
regulate cellular functions when produced in small amounts. Numerous sources of ROS have been 
identified in literature such as xanthine-xanthine oxidases, NADPH oxidases, mitochondrial 
respiration, cycloxygenases, lipoxygenases, and uncoupled nitric oxide synthases [58].  
Nitric Oxide - Under healthy conditions NO• is produced by endothelial nitric oxide 
synthase (eNOS) in blood vessels, however, under inflammatory states, NO• may be produced by 
inducible NOS in macrophages and smooth muscle cells [59, 60]. NO• is a very critical mediator 
SYSTOLE 
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of endothelium-dependent vasodilation. It is also known to maintain balance between growth and 
differentiation of smooth muscle cells and modulate platelet aggregation [61, 62]. 
Peroxynitrite - When O2
•- and NO• are produced simultaneously they react rapidly to form 
another highly reactive molecule peroxynitrite (ONOO•-), which is responsible for lipid 
peroxidation, protein nitration, and is highly proatherogenic [63-65]. 
Superoxide (O2•-) – These molecules are highly unstable and are therefore rapidly 
dismutated by the enzyme superoxide dismutase (SOD) into the more stable molecule, H2O2, 
which is further degraded by either catalase or glutathione peroxidase into water (Fig 2.5) [66-68]. 
O2
•-molecules have a short half-life and are membrane impermeable [69]. They can act as signaling 
molecules altering the function of critical proteins such as enzymes, structural proteins, small 
GTPases, ion channels, phosphatases, and kinases [70]. More importantly they are important 
precursors to other ROS such as H2O2 and highly reactive peroxynitrites. Finally, they serve as 
oxidants and react with DNA, the cell membrane, or biologic macromolecules to further prolong 
the oxidative state of target cells or tissues [58, 65].  
Hydrogen Peroxide (H2O2) - is one of the most stable ROS produced in the vasculature 
that is freely diffusible across the cell membrane, making it an ideal candidate for a signaling 
molecule [71].  It is capable of reacting with a plethora of other molecules. For example, it is able 








Figure 2.5: Chemical Reactions Governing ROS Production in the Vasculature Superoxide 
(O2•-) molecules are generated by the conversion of molecular oxygen by enzymes such as NADPH 
oxidase. Superoxide is then rapidly converted into the more stable H2O2 by superoxide dismutase 
(SOD) or reacts with nitric oxide (NO) to form peroxynitrite (ONOO-). Catalase further converts 
H2O2 into water and oxygen. Adapted from [72] 
 
It is important to note that the effects of these ROS, especially, O2
•- and H2O2, are highly 
dependent on the amounts produced [73]. When produced in low quantities intracellularly, they 
are known to act as second messengers controlling physiologic functions such as growth and 
proliferation in smooth muscle cells [46, 58]. In these conditions, their production and removal are 
tightly regulated, thereby allowing them to have a transient mode of action. However, when these 
two molecules are produced in excess of the body’s antioxidant systems, they modulate 
pathophysiological processes by causing damage to DNA, apoptosis, and potently regulating pro-
inflammatory genes, cell migration, proliferation, adhesion, and other vascular responses [58, 65, 
74].  
Reactive Oxygen Species and Hypertension 
When produced in excess, it is well established that ROS are strongly linked to the 
development and progression of numerous disease pathologies that range from neurological 
diseases such as Parkinson’s and Alzheimer’s, cancer, diabetes, and cardiovascular disease such 
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as atherosclerosis, strokes, aneurysms, myocardial infarction, and hypertension [75]. In arterial 
disease pathologies such as atherosclerosis and hypertension related inflammation, ROS have also 
been implicated in the breakdown of the extracellular matrix (ECM) [72, 76-78].  
ROS produced by NADPH oxidases have been shown to increase ECM degradation by 
increased MMP activation [78, 79].  Since a balance of proteins such as elastin, collagen, and other 
ECM proteins, plays a critical role in the maintenance of an intact artery, oxidative disturbance of 
the ECM can lead to endothelial dysfunction and SMC remodeling and reorganization. This 
breakdown can in turn attract inflammatory cells such as monocytes and macrophages, which then 
propagates the secretion of ECM destroying enzymes such as interleukins, MMPS, and cathepsins, 
leading to a vicious inflammatory cascade and further breakdown of healthy tissue [76, 77].  
It has been also shown that in hypertension, ROS are produced from multiple organs 
systems and cell types that range from neuronal, renal, vascular, and cardiac origin [58], but we 
focus on increased ROS within the vasculature for the purpose of our discussion. Clinical studies 
show that plasma levels of ROS and related large quantities of peroxidation and DNA oxidation 
byproducts significantly increase in the presence hypertension [80]. The role of H2O2 has been also 
elucidated in animal models such as the catalase overexpressing transgenic mouse model, wherein 
increased catalase levels in the vascular smooth muscle, leads to lower H2O2 levels in the medial, 
which ultimately protects the vasculature against AngII induced hypertrophy [81]. Other studies 
using a high salt-intake rat model of hypertension shows that superoxide interacting with NO, 
along with L-buthionine sulfoximine treatments, induces vascular dysfunction [82].  Another study 
demonstrated that potential inhibition of Nox-1 induced ROS using atorvastatin would reverse 





The body has several defense mechanisms to protect itself against excess ROS, which are 
a natural byproduct of metabolism. Most of the molecules and enzymes that work together to 
breakdown these ROS are termed antioxidants. In fact, several studies involving antioxidants have 
shown a critical link between oxidative stress and vascular pathologies. For example, there have 
been studies that show that animals treated with the antioxidant Vitamin E have a lower incidence 
of AAA formation [84]. Additionally, there was a smaller influx of macrophages in the media of 
these Vitamin E treated animals [84].  Conversely, there are clinical studies that have shown that 
hypertensive subjects have lower levels and activity of physiologic antioxidants such as superoxide 
dismutase, catalase, and glutathione peroxidase [68].  
Catalase is an important antioxidant enzyme that converts H2O2 into water and molecular 
oxygen. The work described in this thesis involves the use of the transgenic mouse that 
overexpresses the human catalase gene specifically in vascular smooth muscle cells (TgSMC-Cat) 
[81]. These mice have increased activity of catalase in the SMC and therefore lower H2O2 levels 
in the media of the aorta. As previously mentioned, studies with these mice show that H2O2 within 
the medial layer of the aorta promotes SMC hypertrophy in the setting of AngII infused 
hypertension [81].  
 
Sources of ROS and Hypertension 
There are several sources of ROS in the vasculature that include (a) NADPH oxidases, (b) 
xanthine oxidase, (c) the mitochondrial electron transport chain, and finally (d) the endothelial 
nitric oxide synthase.  
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 NADPH oxidases are membrane bound receptor enzyme complexes that generate 
superoxide and H2O2, especially when stimulated by AngII [45]. They are comprised of multiple 
units that include a catalytic subunit, membrane bound, and NOX domain (Fig 2.6) [85]. They are 
the most common and best studied source of ROS in the vasculature. Compared with NADPH 
oxidases found in phagocytes, vascular NADPH oxidases generate much lower levels of 
superoxide (less than 1%) [86]. Vascular NADPH oxidases also generate superoxide that play a 
vital role in cell signaling as opposed to playing a cytotoxic role which it does in phagocytes. There 
are several kinds of NADPH oxidase homologues expressed in vascular cells of the body ranging 
from NADPH oxidase 1-7 (NOX 1-7). NOX 1, 2, 4 and 5 – are the most commonly found NOXes 
within the vasculature [71, 87]. It is known that endothelial cells express high levels of the NOX 
2 and NOX 4 homologues and low levels of NOX 1 and NOX 5 [71, 87]. Vascular NADPH is also 
regulated by numerous humoral factors such as growth factors, cytokines, and vasoactive 
molecules, and several physical factors such as shear stress, cyclic strain, and stretch [88].  
 Several animal studies have shown that NADPH oxidase activity and expression is 
upregulated in the setting of hypertension. Animal studies involving spontaneously hypertensive 
rats (SHR) have shown increased NAPDH oxidase dependent superoxide production in large 
arteries such as the aorta [89-91]. Another important discovery is that several polymporphisms in 
the promoter region of the p22phox gene (note that p22phox is a subunit of the NADPH oxidase 
complex) have been observed in the animal model of SHR [92]. This discovery has major 
implications because other clinical studies have shown that in patients suffering from hypertension, 
there is a strong link between a p22phox gene polymorphism and NADPH oxidase dependent 




Figure 2.6: Structure of the NADPH Oxidase 4 Enzyme ROS are generated by the conversion 
of molecular oxygen into superoxide and then rapidly into hydrogen peroxide by enzymes such as 
NADPH oxidase as shown above. This enzyme comprises of multiple subunits (such as NOX4, 
p22phox, and Poldip2) across different cellular components (vesicle, cytosol). Adapted from [74] 
 
Xanthine oxidases - These enzymes are another important source of superoxide. The ROS 
producing form of xanthine oxidoreductase comprises of XO which uses oxygen as an electron 
acceptor [70, 93]. There is another non-ROS producing form of xanthine oxidase also referred to 
as XDH [70, 93]. The XDH to XO ratio determines the oxidative state of the cell. A transition in 
this ratio from XDH to XO can occur via inflammatory cytokine stimulation and by cysteine 
residue oxidation by ROS such as peroxynitrites. Activation of NADPH oxidases can also further 
trigger the balance of XDH to XO, in favor of XO further inducing oxidative stress [70, 93].  
Mitochondrial electron transport chain is another major contributor of ROS in the 
vasculature [70]. The mitochondrial electron transport chain works through a series of complexes 
(1-4), that pass an electron from one complex to the next. The final transfer of this electron to an 
oxygen molecule is what generates superoxide.  
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Endothelial Nitric Oxide Synthase (eNOS) – In the healthy vasculature, this enzyme is 
highly expressed and is thereby responsible for the synthesis of the atheroprotective molecule NO.  
This enzyme typically comprises of two subunits. Under conditions of oxidative stress, however, 
these subunits uncouple and they generate ROS [70, 93, 94]. As the vascular cells further shift into 
an oxidative state, some of the eNOS continues to remain coupled, and produce NO, which in turn 
reacts with superoxide generated by the uncoupled eNOS, resulting in a plethora of undesired 
ROS, ultimately leading to a pro-inflammatory state and vascular dysfunction [70, 93, 94].  
 
Osteopontin: Structure, Function, and Role 
 Osteopontin (OPN) is a multifunctional, non-collagenous ECM protein [95]. It is 
commonly categorized as a matricellular protein. These proteins are found in the extracellular 
space, but unlike ECM proteins do not play any structural or mechanical role within tissues they 
are expressed in [96]. OPN is found abundantly in the matrix of several mineralized tissue such as 
the bone, where it was first discovered in the late 1970s [97]. Within cells, OPN is first synthesized 
as a 34-kDa protein and then undergoes several post-translational modifications that include 
phosphorylation and glycosylation, depending on its site of expression [97]. OPN is known to bind 
to hydroxyapatite and to calcium because of its negative charge and acidic nature [95]. Early 
research surrounding OPN focused on its role within bones, but it was soon discovered that OPN 
played an important role in tissues undergoing active remodeling, inflammation, wound repair, 
metastasis, tumor formation, cell migration, adhesion, and mineralization [95]. OPN can respond 
to and interact extremely efficiently with surrounding cells and proteins because it contains an 
RGD sequence known to bind to integrins, thrombin cleavage site, and additional sequences 
known to bind to the CD44 (hyaluronic acid) receptors [95].  
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Integrin mediated signaling is a critical link between cells and their external environments, 
and even more relevant in the setting of hypertension, because of the need for vascular cells to be 
able to respond to changing physical forces (such as elevated blood pressure) [98]. OPN is able to 
successfully interact with integrin receptors, thereby not only allowing cells to adhere to their 
ECM, but also mechanotransduce external signals into the nucleus, alter gene expression and their 
overall response [98]. The family of integrin receptors that are currently known to interact with 
OPN include αvβ1, αvβ3, αvβ5, α4β1, α5β1, α8β1, and α9β1. OPN is able to interact with most 
integrins thorough its RGD motif, except for α4β1 and α9β1 which interacts with a novel amino 
acid binding sequence – SVVYGLR [95, 98-102]. OPN has a thrombin cleavage site which is 
believed to increase the access of numerous cell receptors to their binding domains and allow for 
better enhanced cellular effects of OPN [103]. The other important OPN receptor CD44, is a 
glycoprotein and allows for cell migration and adhesion [104]. The principal ligand for CD44 is 
hyaluronic acid, but it binds to other proteins such as OPN and other ECM proteins like fibronectin, 
laminin, and collagen [105].  
 OPN affects cell migration, chemotaxis, and adhesion through its several binding domains 
and therefore, its role in several disease pathologies that involve wound repair, tumor growth, 
metastasis, and inflammation has been well defined and studied. OPN plays an important role in 
immune cell migration and in mediating the overall inflammatory response of tissues to injury [95, 
106]. OPN is known to mediate immune response to bacterial and viral infections and act as a 
potent chemoattract for macrophages at sites of inflammation [107]. These effects of OPN on 
immune cell migration and activation provide strong evidence in support of the hypothesis that 
OPN plays an important role in wound repair and tissue remodeling. These effects are also 
supported by the early observations made of the OPN KO mice generated by Liaw et al. that 
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demonstrate reduced macrophage infiltration and matrix organization in response to skin injury 
[108]. Studies have shown that OPN is also highly expressed in the blood and in tumors that are 
in advanced stages and undergoing active metastasis [109].  
 
Osteopontin in Vascular Pathophysiology & Regulation 
In the vasculature, it is established that OPN is present only in small amounts in the 
uninjured arteries, however, its expression increases several fold in endothelial, smooth muscle, 
and activated inflammatory cells in injured arteries [5, 95, 110]. The functional role of OPN in this 
inflammatory setting has been attributed to its role as a chemo attractant for endothelial cells and 
smooth muscle cells, inhibitor of calcification, and activator of inflammatory cells [5, 102, 111]. 
Furthermore, it has been observed that OPN protein and mRNA are expressed in higher levels at 
sites of dystrophic calcification, atherosclerotic plaques, and in macrophages present in calcified 
aortic valves [5, 110, 112]. OPN has also been implicated to play a critical role in wound healing, 
collateral vessel formation, vascular remodeling, and development of atherosclerosis [110].  
Several studies from our lab have shown that OPN plays a critical role in 
neovascularization within the hind limb [113, 114]. Studies by Duvall et al provide early evidence 
that OPN plays a critical role in ischemic limb revascularization and suggest that this maybe driven 
by macrophage and monocyte inflammation at the site of injury, which was impaired in OPN KO 
mice with hind-limb ischemia [113]. Furthermore, in-vitro and in-vivo studies by Lyle et al 
demonstrate that OPN is regulated by ROS such as hydrogen peroxide [7]. Animal studies of hind 
limb ischemia in transgenic mice that overexpress catalase in vascular smooth muscle cells (TgSMC-
Cat) animals demonstrate that hydrogen peroxide plays an important role in mediating OPN 
expression in response to hind limb ischemia [114].  In-vitro studies by Lyle et al further elucidates 
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the specific cellular mechanisms by which hydrogen peroxide regulated OPN expression via 
activation of transcriptional and translational pathways [7]. 
Finally, several clinical studies have shown that there are elevated levels of OPN detected 
in plasma of hypertensive individuals [115]. However, it is unknown why OPN is upregulated and 
its specific functional role in the setting of hypertension is also unclear. As previously mentioned 
OPN is a matricellular protein that acts to translate mechanical cues into cellular signaling within 
the vascular wall [116], but its expression in response to mechanical strain from the vascular wall 
in response to hypertension has not been explored before. It is therefore critical to study its 
response to increased cyclic stretch in a controlled in-vitro and in-vivo setting, and is therefore, the 




REGULATION OF OSTEOPONTIN IN-VITRO BY CYCLIC STRAIN IN AORTIC 
SMOOTH MUSCLE 
SPECIFIC AIM 1: 
Establish if mechanical strain in-vitro increases osteopontin expression 
Introduction 
Uncontrolled high blood pressure is a major risk factor for a plethora of cardiovascular 
pathologies that range from atherosclerosis, aneurysms, dissections, strokes, heart failure, and 
myocardial infarctions (MI). There are numerous factors that are dysregulated with the onset of 
hypertension and these can be broadly classified into two categories – humoral and mechanical. 
Humoral factors include higher levels of circulating agonists such as AngII and NE, while 
mechanical factors include increased circumferential vascular wall strain as a result of elevated 
blood pressure. The current body of literature reflects a much greater emphasis placed upon the 
study of the effects of humoral factors on the vasculature [3, 36, 41, 53, 83] both in-vivo and in-
vitro, but little is known about the effects of increased mechanical strain on the arteries [3, 4]. In 
reality, however, the progression of arterial inflammation is likely due to a combination of both 
these factors and not just one.  
Our first objective, therefore, was to determine the effect of mechanical strain on the 
expression of the pro-inflammatory protein, OPN, in isolated vascular smooth muscle cells in 
culture, and to study if this was a redox sensitive mechanism (Fig 3.1). We used a computer 
controlled bioreactor that applied uniform, reproducible biaxial strain to SMCs. Following 
treatment, the media surrounding these SMCs and the cells themselves were harvested and 
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analyzed for H2O2, protein, and mRNA levels using techniques including Amplex Red Assay, 
Western blot analysis, ELISA, immunohistochemistry, and quantitative real time PCR (qRT-
PCR).  
 
Figure 3.1: Suggested Mechanism of Mechanical Strain Induced OPN Expression We 
hypothesize that OPN expression is increased when smooth muscle cells experience cyclic 
mechanical strain, and that this happens via increases in hydrogen peroxide and an NADPH 






























Cell Culture & Materials 
Vascular Smooth Muscle Cells (SMCs) were harvested by enzymatic elastase/collagenase 
digestion from rat thoracic aorta, as previously described [117]. SMCs between passage 6 and 14 
were cultured on silicone membrane 6-well plates that had been coated with collagen type - I 
(Bioflex © Culture Plates, Flexcell International) and grown in DMEM (Sigma Aldrich, St Louis, 
MO) which was supplemented with 10% calf serum (Invitrogen), 2mmol of L-glutamine, 
100U/mL of penicillin, 100ug/mL of streptomycin, and 1M of HEPES solution. SMCs were then 
quiesced by serum starvation in 0% calf serum containing DMEM for 48 hours. Note that media 
was changed every 24 hours during the period of quiescence. Polyethylene-glycol catalase (PEG-
Catalase), Polyethylene-glycol superoxide disumatase (PEG-SOD), Apocynin (200ug/mL), and 
Diphenyliodinium (DPI, 10uM) were all obtained from Sigma Aldrich.  
 
Cyclic Strain of Vascular Smooth Muscle Cells 
After quiescing SMCs, cells were stretched at 10% cyclic strain on the computer controlled 
Flexcell® FX-5000 Tension System in all experiments unless stated otherwise. This system uses 
a patented, computer controlled, pressurized device that applies a reproducible, user defined cyclic 
tension. In this device, cells cultured in a monolayer on elastomeric, flexible bottom culture plates 
experience equibiaxial strain when the plate is deformed using a regulated vacuum pressure (Fig 
3.2 and Fig 3.3). Cells of the control group were seeded in an identical manner on identical flexible 
bottom culture plates, but did not experience any cyclic strain, and were kept on another stationary 




Figure 3.2:  Schematic of Application of Biaxial Strain on a Single Well of Cultured Vascular 
Smooth Muscle Cells. SMCs are cultured on flexible membrane Collagen-I coated 6-well plates 
that are then mounted over a loading platform controlled by the FX-5000 Tension System. This 
system utilizes a computer controlled, pressure operated mechanism to apply reproducible, 
equibiaxial strain on cells that are located directly over the loading platform. Application of a 
uniform cyclic vacuum pressure (bottom two images) pulls the membrane with cells over the 
loading platform to generate the desired magnitude of strain, thereby straining cells. 
Western Blot Analysis 
SMCs were lysed in Hunter’s Buffer, as previously described [118]. Cells were sonicated 
using a sonic dismembrator at 10W for 10 x 1 sec pulses. Whole cell lysates were then boiled and 
subsequently used for immunoblotting. Band intensity was quantified by densitometry analysis 
and normalized to β-Actin. The OPN antibody was purchased from R&D systems (Cat#: AF808). 
The β-Actin antibody was from Cell Signaling (Cat# 13E5). 
ELISA 
Secreted OPN expression was measured using a rodent OPN ELISA kit obtained from 
Enzo Life Sciences and manufacturer’s instructions were strictly followed. DMEM from cyclically 
strained SMCs was harvested and stored with protease inhibitor cocktail (PIC) from Sigma. 
 







Figure 3.3:  Phenotype of Rat Aortic Smooth Muscle Cells 24h post Strain Rat aortic smooth 
muscle cells were stained for Phalloidin (green) and DAPI (blue). Cells located near the 
circumference of the Collagen-I coated flexible membrane plates are observed to align tangentially 
in response to cyclic strain. Images courtesy of Dr. Alejandra San Martin.  
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RNA Isolation and Quantitative Real-time Polymerase Chain Reaction 
RNA was harvested from aortas or cultured SMCs in RLT Buffer and processed for mRNA 
using the RNEasy kit from Qiagen. OPN mRNA levels were then measured by amplification of 
cDNA using an Applied Biosystems thermocycler, primers specific for mouse or rat OPN 
(QuantiTect Primers, Qiagen), and SYBR green dye. Copy numbers were calculated by the 
instrument software from standard curves of genuine templates. OPN copy numbers were then 
normalized to a million copies of the housekeeping gene 18s. 
 
Detection of ROS  
The production of superoxide (O2
·-) was measured via immunocytochemistry using 50M 
of hydrocyanine-3 fluorescent probe (ROSstar 550 Probe). H2O2 production was measured using 
the Amplex Red Assay Kit (Invitrogen) as previously described [67].  
 
Statistics 
All results are presented as mean ± SEM and analyzed using ANOVA or t-test using 
GraphPad TM Prism Software (GraphPad Prism), followed by Bonferroni or Tukey multiple 






Cyclic Strain Increases Osteopontin Expression in Cultured SMCs 
            At the onset of hypertension, it is well established that the vessel wall experiences increased 
levels of cyclic mechanical forces such as elevated circumferential vascular wall strain. We wanted 
to study the independent effect of elevated cyclic strain on OPN expression and therefore first 
conducted a time-course study where rat SMCs were strained at 10% elongation for 2, 4, 8, and 24 
hours. Following strain, SMCs were harvested and analyzed for OPN levels. We observed a 
significant increase in OPN mRNA in the SMCs strained for 24 hours compared to the non-strained 
control cells (Fig 3.4). We did not observe any significant increase in OPN mRNA at any of the 
earlier time points (2, 4, or 8 hours). OPN protein expression was also measured using Western 
blot analysis (Fig 3.5) after straining SMCs at the time points previously mentioned and we 
observed a significant increase at the 24-hour time point. We did not observe any significant 
change in cellular OPN levels at the earlier 2, 4, or 8-hour time points, similar to what was observed 
with OPN mRNA.  
Finally, it is known that OPN is a secreted protein, and therefore, we measured 
secreted levels of OPN (from the media surrounding the strained cells) using an ELISA (Fig 3.6) 
and found that SMCs strained for 24 hours secreted ~4 fold-higher levels of OPN compared to the 
non-strained controls. Combined, these results demonstrate that osteopontin is indeed a 





Figure 3.4:  24 hours of Cyclic Strain Increases OPN mRNA Expression SMCs were cyclically 
strained for 2, 4, 8, and 24 hours and then harvested for analysis. Quantitative real-time PCR was 
used to measure levels of OPN mRNA that were normalized to a million copies of the 18s 
housekeeping gene.  Samples were obtained by straining RASMs for 24hrs at 10% elongation. 
*p<0.05 for N=3. Black bars represent the SMCs strained at 10%, while the white bars represent 
the control, non-strained SMCs. We observed a significant increase in OPN mRNA expression 




















































Figure 3.5:  24 hours of Cyclic Strain Increases Cellular OPN Protein Expression OPN protein 
expression was measured SMCs via Western Blot analysis after 2, 4, 8, and 24 hours of cyclic 
strain.  Protein expression was quantified via protein densitometry and is represented in arbitrary 
units normalized to β-Actin expression *p<0.0.5, N=4. Black bars represent the SMCs strained at 
10%, while the white bars represent the control, non-strained SMCs. We observed a significant 
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Figure 3.6: Cyclic Strain Increases Secreted OPN Protein Expression Secreted OPN protein 
expression was measured in conditioned media using an ELISA after SMCs were strained at 10% 
for 24 hours ***p<0.001, N=3. Secreted OPN expression in SMCs was increased significantly by 









































Osteopontin Expression Increases with Varying Degrees of Strain, but is not Dependent on 
Strain Magnitude 
The cells of the aorta experience average circumferential cyclic strains that range 
from around 5 to 25% or more [119], depending on the physiologic state of the organism. 
Furthermore, these strain levels chronically change from a healthy to diseased state, and 
specifically in the setting of hypertension, this circumferential strain is increased [119]. For this 
study, we wanted to identify the effect of varying degrees of cyclic strain on the expression of 
OPN. We, therefore, strained SMCs at 5, 10, 15, and 20% cyclic strain for 24 hours and harvested 
the cells for protein and analyzed cellular OPN levels via Western blot analysis. We hypothesized 
that the increase in OPN would be proportional to the degree of strain that the SMCs were 
experiencing. We observed that OPN had a trending increase at all levels of cyclic strain, with the 
most significant change (~6-fold increase) observed with 10% cyclic strain for 24 hours (Fig 3.7). 
There was a trend towards a 2 to 4-fold increase in OPN expression observed at the other strain 
magnitudes of 5, 15, and 20%, but these were not statistically significant, for an N=3. These results 
suggest that OPN is indeed mechanosensitive and is upregulated with varying levels of cyclic 
strain, however, this increase is not strain magnitude dependent.    





Figure 3.7: Varying Magnitudes of Cyclic Strain Increases OPN Protein Expression OPN 
protein expression was measured in SMCs via Western Blot analysis after cyclic strain at 5, 10, 
15, and 20% Strain.  Protein expression was quantified via protein densitometry and is represented 
in arbitrary units normalized to β-Actin expression ***p<0.001, N=3. OPN expression is observed 
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Cyclic Strain Increases Reactive Oxygen Species (ROS) in SMC in Culture 
Several human clinical and animal studies of hypertension show compelling evidence of 
the role of ROS in cardiovascular disease progression [39]. ROS play an important role as second 
messengers and in signal transduction, especially in cardiovascular pathophysiology. In this study, 
we measured levels of ROS in SMCs following cyclic strain using the fluorescent hydrocyanine-
3 dye. We found that cyclic strain of SMCs after 4 hours increased levels of superoxide (O2
-·) 
compared to non-strained SMCs. Representative images from a set of three independent 
experiments is shown in Figure 3.8 and quantified below. Superoxide Dismutase (SOD) is an 
enzyme that converts the superoxide molecule into hydrogen peroxide. In order to determine if the 
signal observed using the hydrocyanine-3 dye was specific to increases in superoxide, we strained 
SMCs with Polyethylene Glycol Superoxide Dismutase (PEG-SOD) and this blunted the increased 
red fluorescence signal that was previously observed.  
Hydrogen peroxide is an important byproduct of cellular metabolism, especially in the 
vasculature. When produced at high concentrations it is capable of causing DNA strand breaks, 
but at low concentrations it plays an important signaling role [94]. We wanted to study, whether 
cyclic strain also increases levels of the more stable hydrogen peroxide. The Amplex Red assay 
was used to measure levels of hydrogen peroxide after strain (Fig 3.9) and we observed that SMCs 
strained for 4 hours show a significant approximately 4-fold increase in H2O2 levels (p<0.05) 
compared to non-strained cells. Note that this increase represents a snapshot of the H2O2 levels 






Figure 3.8: Cyclic Strain for 4 hours Increases Superoxide (O2-) (I) Superoxide levels were 
measured using the hydrocyanine-3 fluorescent dye. RASMs were strained for 4 hours prior to the 
addition of hydrocyanine-3 dye. Fluorescence images were then taken at 10X magnification for 
N=3. Representative images are shown. (I and II) An increase in superoxide levels was observed 
in the cells strained for 4 hours (panel b) compared to the unstrained control (panel a). 
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Figure 3.9:  Cyclic Strain Significantly Increases H2O2 Amplex Red Assay was used to measure 
levels of hydrogen peroxide.  Total concentration of H2O2 was normalized to total protein and the 
fold increase plotted against control at each time point. Control sample represents RASMs exposed 
to no strain for 12 hours. All other samples were obtained by straining RASMs for 2, 4, 8, and 12 
























































NADPH oxidases play an Important Role in Mediating Cyclic Strain-induced Increase in 
OPN Expression in Culture 
NADPH oxidases are an important enzymatic source of ROS in SMCs, and we wanted to 
determine if they were upstream of cyclic strain-induced ROS and OPN expression. In this set of 
experiments, we used two inhibitors of NADPH oxidases – diphenyliodinium (DPI) and apocynin 
– while cyclically straining vascular smooth muscle cells.  
DPI is used as a non-competitive inhibitor of flavoenzymes – and NADPH oxidases belong 
to this family of enzymes [120]. It was originally discovered to be a hypoglycemic agent that could 
block respiration and gluconeogenesis [120], but was later discovered to block the activity of 
flavoenzymes such as NADPH oxidases, nitric oxide synthases, and xanthine oxidase [120]. DPI 
is thought to abstract an electron from the FAD subunit which results in a radical. This then binds 
irreversibly to the FAD subunit of NADPH oxidases, irreversibly and rapidly blocking their 
activity [75, 121].  
Apocynin is another non-specific NADPH oxidase inhibitor used in these studies that is 
believed to inhibit the assembly of the NADPH oxidase subunits. Apocynin is also known to have 
ROS scavenging activity [122, 123].  
SMCs strained for 24 hours in the presence of DPI demonstrated a significant decrease in 
OPN protein expression compared to untreated, strained RASMS (Fig 3.10). Similar decreases in 
OPN expression were measured in the SMCs strained in the presence of apocynin (Fig 3.11). These 
data suggest that NADPH oxidases potentially play a role in mediating mechanical strain 
dependent increases in ROS and OPN. Although further studies will have to be conducted to 





Figure 3.10: Strain-Induced Increase in OPN Expression was Blunted in the Presence of DPI 
OPN protein levels were measured using Western Blot analysis and normalized to β-Actin 
expression. The 1st lane is the control sample obtained from RASMs not exposed to strain and DPI, 
2nd lane is the sample obtained from non-strained RASMs with DPI, 3rd lane is the sample from 
RASMs strained for 24hrs without any DPI, and the 4th lane is sample obtained from RASMs 
strained for 24h in the presence of DPI. **p=<0.01, N = 3. We observed that strain-dependent 




































































Figure 3.11: Strain-Induced Increase in OPN Expression was Blunted in the Presence of 
Apocynin OPN protein levels were measured using Western Blot analysis and normalized to β-
Actin expression. The 1st lane is the control sample obtained from RASMs that were not exposed 
to cyclic strain or apocynin, 2nd lane is the sample obtained from non-strained RASMs, but exposed 
to apocynin only, 3rd lane is the sample from RASMs cyclically strained for 24hrs without any 
apocynin, and the 4th lane is the sample from RASMs cyclically strained for 24h and also exposed 










































































 Early in-vitro studies using aortic smooth muscle, in the late 1970s, by Leung et al. focused 
on the effect of cyclic strain on the synthesis of extra-cellular matrix proteins. It was discovered 
that there was a significant increase in the rate of synthesis of collagen, hyaluronate, and 
chondroitin 6-sulfate [124]. It was further noted in this study that the increase in ECM protein 
synthesis was not dependent on an increase in cell number or DNA synthesis rates [124]. Another 
early study looked at the effect of pulsatile stretching on the orientation of smooth muscle cells, 
and it was observed that more than 75% of the cells reoriented themselves within 45 degrees of a 
line at a right angle in the direction of stretch [125]. Finally, Lundberg et al highlighted that 
mechanical strain impacts cell proliferation and that this was dependent on the ECM composition 
and origin of the SMC [126]. These early studies highlight the physical behavior of smooth muscle 
cells and their impact on ECM in response to stretch.  However, the specific contribution of 
elevated cyclic strain in accelerating the process of arterial inflammation has not been adequately 
explored, and the basic underlying molecular mechanisms leading to hypertension associated 
vascular complications still remain largely unknown.  
Therefore, the primary objective of this aim was to use an in-vitro system to study the 
impact of cyclic mechanical strain on the expression of the potent pro-inflammatory protein, 
osteopontin (OPN), and its regulation in aortic smooth muscle cells. Our hypothesis was that cyclic 
strain would elevate OPN expression and that this would occur via a redox sensitive pathway. To 
our knowledge, the results of these studies provide first evidence that  
1) OPN is upregulated with cyclic mechanical strain in cultured vascular smooth muscle cells as 




2) this upregulation of OPN protein was maximal at 10% Strain (Fig 3.7), and that,  
3) cyclic strain-induced OPN is potentially mediated by NADPH oxidases – the primary 
enzymatic source of ROS in the vasculature (Fig 3.10-3.11). However, the specific NADPH 
oxidase regulating this process, still remains to be determined. 
Indeed, many of our results are corroborated by other studies from our group and other 
researchers who focus on the strain-dependent regulation of proteins involved in vascular 
remodeling and inflammation in arteries. For example, in one study by Grote et al., cyclic strain 
was shown to impact proteins involved in vascular remodeling such as matrix metalloproteinases 
(MMPs), that are responsible for the breakdown of the vascular ECM scaffold [79]. This study 
also went onto prove that cyclic strain of SMCs increased release of the proenzyme and mRNA 
expression of MMP-2, and that this was mediated by NADPH oxidase-derived ROS [79]. Our 
results implicate a role for NADPH oxidases in mediating increases in cyclic strain-induced OPN.  
Our results from aim 1 also validate previous findings that highlight that the cyclic nature 
of the mechanical stimulus is critical in observing these changes. Studies from our groups and 
others have shown previously that a significant increase in hydrogen peroxide is observed only in 
the setting where cyclic strain (1Hz, 20% strain) was applied to aortic endothelial cells [4, 127]. 
In cells that were exposed to a static strain (only 20% strain) no increase in hydrogen peroxide was 
observed [4]. These observations, therefore, prompted us to conduct our experiments in aim 1 
using cyclic and not static strain.  
We also observe increased levels of both superoxide and hydrogen peroxide with cyclic 
strain (Fig 3.8 and 3.9) and these are supported by several studies in literature. Some in-vitro and 
ex-vivo studies have shown that a cyclic strain of 10% and 20% stimulate an increase in superoxide 
[127-129], however, strain magnitudes of 5% and 6% fail to do so [127-129]. These results suggest 
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that a minimum threshold strain magnitude maybe necessary for the active production of ROS in 
these cells. Our experiments were conducted at a strain magnitude of 10%, and we do see 
significant increases in ROS as early as 4 hours, and hence these findings are in line with previous 
studies as described in literature. Our results from the strain dependent experiments also show that 
there is a maximal increase of OPN at 10% strain, but a lower increase at the higher strain 
magnitudes (15% and 20%). We speculate that this lower OPN expression at higher strain 
magnitudes, may imply a maladaptive response of aortic SMCs as they experience higher strain 
magnitudes. 
With regard to the regulation of OPN, studies by Lyle et al. have demonstrated that OPN 
mRNA and OPN protein (both cellular and secreted) expression are increased in the presence of 
hydrogen peroxide in cultured SMCs [7]. We observe in this aim that ROS (such as hydrogen 
peroxide and superoxide) are increased with cyclic strain. We further note that inhibiting NADPH 
oxidases, a major source of these ROS, reduces OPN expression. These results together, therefore, 
strongly suggest that cyclic strain-dependent increase in OPN is redox-sensitive, and further 
validate the observations made by Lyle et al [7].  
As for the time course of the increase in OPN in our studies, it was interesting to note that 
both OPN mRNA and protein expression were upregulated only at the 24-hour time point (Fig 
3.5). On the other hand, ROS levels (both superoxide and hydrogen peroxide) were increased at 
the earlier 4-hour time point (Fig 3.8 and 3.9). This suggests that there may be a delay in OPN 
transcription, in response to cyclic strain. Studies on the direct effects of hydrogen peroxide on 
OPN expression, have in fact shown that there are late (18h) transcriptional increases in OPN 
protein expression, regulated by the binding of the redox sensitive transcription factors AP-1 and 
NF-B, to the OPN promoter region, in response to hydrogen peroxide treatment [7].  These results 
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validate our observations, and provide a possible explanation for the delayed increase of OPN 
protein expression in response to cyclic strain, despite the early increase in hydrogen peroxide.  
Finally, it has been documented that AngII, a critical mediator of vasoconstriction and 
blood pressure, upregulates OPN expression in SMCs [130]. AngII is well documented to increase 
levels of NADPH oxidase-derived ROS [45], and therefore, these ROS maybe the potential 
mediators by which AngII-dependent increase in OPN occurs as well, which further supports the 
findings of this study.   
As for some of the limitations and assumptions made in this study, a major assumption 
made for the purpose of this study, was that the applied mechanical strain is equal to the actual 
mechanical strain experienced by the cells. This assumption, however, is not entirely true as noted 
by the results of a finite element analysis (FEA) of the strain profiles of these flexible membranes 
[131]. The FEA simulations suggest that the regions of the membrane located off the loading post 
experience large radial strains and small circumferential strains, while the regions located directly 
above the loading post experience equal, but large radial and circumferential strains (see Fig 3.2). 
This potential inconsistency in the biaxial strain experienced by all cells within the Flexercell 
device, may explain why we fail to see a strain dose-dependent change in OPN expression as 
observed in Figure 3.7. In future experiments, separating cells from the regions located off the post 
from those located directly above the post, may give us clearer answers on the effect of cyclic 
strain on OPN expression.  
Overall the results of this aim support the following conclusions: 
1) that OPN is indeed a mechanosensitive protein whose expression is upregulated with 
cyclic strain in vascular smooth muscle cells, independent of strain magnitude, and that 
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2) the strain-dependent increase in OPN is mediated by NADPH-oxidases and potentially 
by ROS, although future studies are needed to further clarify the specific NADPH 
oxidase(s) and specific ROS that mediate this increase. 
 Our in-vitro results provide a novel mechanism for the strain-dependent regulation of OPN 
and a potential target to consider while designing therapeutics to address the severe cardiovascular 





HYPERTENSION UPREGULATES OSTEOPONTIN VIA A H2O2 DEPENDENT 
MECHANISM 
SPECIFIC AIM 2: 
To determine if osteopontin expression is increased in a murine model of hypertension and if this 
increase is H2O2-dependent  
Introduction 
 Hypertension has been recognized as a major risk factor for several inflammatory diseases 
of the cardiovascular system such as atherosclerosis, myocardial infarctions (MI), and strokes [2, 
24, 25]. Uncontrolled hypertension leads to alterations in the aorta including oxidative stress, 
significant increases in inflammatory chemokines [132] infiltrating leukocytes and macrophages, 
and changes in extra-cellular matrix (ECM) components such as elastin and collagen [133], all 
leading up to hypertrophy and aortic adaptive or maladaptive remodeling.  
Oxidative stress has been inextricably linked to inflammation of the aorta. ROS have been 
shown to have pathological effects on a wide range of biomolecules, as well as modulate 
transcription factors and redox-sensitive signal transduction pathways [134]. AngII and 
mechanical stress are stimuli known to rapidly increase ROS levels by promoting the assembly of 
NADPH oxidase enzymes [88]. Hypertension induces long term exposure of the vasculature to 
these stimuli, which then results in the upregulation and increased activation of NADPH oxidase 
(NOX), and ultimately sustained increases in ROS levels [88]. These in turn activate signaling 
pathways that include c-Jun N-terminal kinase (JNK), mitogen-activated protein kinase (MAPK), 
and redox-sensitive transcription factors such as AP-1 and NF-b [135-137]. NF-b is known to 
serve as a transcription factor for several cytokines and adhesion molecules such as VCAM-1, 
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ICAM-1, and E-selectin [7, 138, 139]. These events lead to the activation and infiltration of 
inflammatory cells including leukocyctes, macrophages, and monocytes. These cells in turn 
produce more ROS which leads to a self-perpetuating cycle of oxidative stress and inflammation 
which in turn results in the remodeling of the arterial wall and its potential degeneration. 
Osteopontin (OPN) has recently emerged as a key factor in the progression of 
atherosclerosis and vascular wall remodeling [115]. Studies have shown that OPN promotes 
adhesion and migration of macrophages [140] and SMC proliferation [141]. Elevated OPN mRNA 
has been identified in human atherosclerotic lesions within the carotid, coronary, and aorta [5, 115, 
142, 143]. Finally, mice overexpressing OPN show an increase in medial thickness and neointimal 
formation after arterial balloon injury [110].  
In addition to these studies and our results from Aim 1 that show an increase in osteopontin 
(OPN) with cyclic strain in-vitro, we were strongly motivated to investigate whether OPN was 
increased in the aorta with the onset of hypertension. We wanted to further identify if this increase 
in OPN was mechanistically linked to the more stable ROS, hydrogen-peroxide. We used two well 
established models of murine hypertension that involved continuous infusion of the vasoactive 
factors –AngII and NE. We further utilized a genetic murine model that overexpresses catalase 
specifically in vascular smooth muscle cells (SMCs) in order to test the role of hydrogen peroxide 
in regulating OPN expression.  This SMC-specific catalase overexpression mouse model was 









Eight to ten week old male C57BL/6 mice were purchased from Jackson Laboratories (Bar 
Harbor, ME). Transgenic mice with smooth muscle cell (SMC)-specific catalase overexpression 
(TgSMC-Cat) were bred in-house in the Department of Animal Resources at Emory University. 
TgSMC-Cat mice have elevated expression of human catalase through the SMC-specific smooth 
muscle myosin heavy chain promoter and were characterized previously [144]. For all 
experiments, eight to ten week old TgSMC-Cat were compared with WT littermates. It is important 
to note that these TgSMC-Cat mice are on a C57BL/6 background. The animals were housed and 
cared for according to the guidelines approved by the Emory University Institutional Animal Care 
and Use Committee (IACUC).  
 
Osmotic Minipump Implantation 
Mice were anesthetized using 1% isofluorane (oxygen delivered at 0.5L/min with 2% 
isofluorane for induction and 1% isofluorane for maintenance). Ang-II (Sigma Aldrich, A6402) at 
a dose of 0.75mg/kg/day or NE (Sigma Aldrich, A9512) at 5.6mg/kg/day were infused via a primed 
mini-osmotic pump (Alzet mini-osmotic pump, Model 2004). The pumps were inserted 
subcutaneously, on the back. Following surgery, mice were administered buprenorphine (1mg/kg, 








Measurement of Systolic Blood Pressure 
Mice were first acclimatized to the tail-cuff plethysmograph (Visitech© Corporation) for 
at least three consecutive days. Systolic blood pressure was then measured prior to and after 
infusion of AngII or NE.  
 
Immunohistochemistry 
Mice were euthanized by slow CO2 inhalation and tissues were perfused with saline and 
fixed with 10% buffered formalin. Whole aortas were excised, paraffin embedded, and cut into 5 
µm sections. Enzyme treatment was performed for antigen retrieval using protease K 10ug/ml for 
30 minutes, before incubation with OPN antibody (1:100 in 5% BSA, R&D), followed by 
incubation with anti-goat secondary antibody (1:400 in 5% BSA; Vector Labs) and incubation 
with streptavidin QDot 655 (1:200 in 5% BSA; Invitrogen). Images were acquired from a Zeiss 
Axioskope microscope equipped with an AxioCam camera. 
 
Protein Analysis 
Mice were euthanized by slow CO2 inhalation. Aortas were rapidly cleared of excessive 
perivascular fat and snap frozen in liquid nitrogen and stored at minus 80C until further 
processing.  Aortas were homogenized on ice using 500-1000uL of Hunter’s Buffer. The 
homogenized samples were then centrifuged at 4C and the resulting supernatant used. Total 
protein quantification was first performed via the Bradford assay using a BSA Standard Curve. 
The protein supernatant was then boiled after the addition of a 1X Laemmli’s buffer and -
mercaptoethanol. 10-20 g of total protein from each sample was then loaded onto a precast 10% 
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polyacrylamide gel and allowed to run in an electrophoresis chamber at 200V for approximately 
an hour. The separated proteins were transferred onto a nitrocellulose membrane at 100V for 2 
hours at 4C. The nitrocellulose membrane was blocked for 1 hour at room temperature in 5% 
milk (Biorad) prepared with a solution of 1% TBS/0.1% Tween (TBST). The membrane was then 
incubated with OPN primary antibody used at a dilution of 1:500 (R&D systems). Secondary 
antibody (donkey anti-goat, Biorad) was used at a dilution of 1:2000. Both primary and secondary 
antibodies were diluted in 5% milk (Biorad) prepared with a solution TBST. The membranes were 
washed 3 times for 10 minutes between primary and secondary incubations using TBST and finally 
incubated with chemiluminescent detection reagent (Amersham ECL). Kodak Scientific Imaging 
Film was then exposed to the processed membrane for around 30 seconds to 2 minutes in a dark 
room. The developed film was scanned and analyzed by densitometry analysis for OPN protein 
expression and normalized to the housekeeping protein β-Actin. The primary β-Actin antibody for 
normalizing the OPN protein data was used at a dilution of 1:2000 and was obtained from Cell 
Signaling. The secondary antibody used was anti-Rabbit at a 1:2000 dilution as well, and obtained 
from Biorad.  
 
RNA Isolation and Quantitative Real-time Polymerase Chain Reaction 
RNA was extracted from aortas that were snap frozen using the RNEasy kit from Qiagen, 
Valencia, CA, and according to protocol. RNA levels from each sample was quantified using 
absorbance values at 260nm obtained using a benchtop spectrophotometer. cDNA was first 
prepared from the obtained aortic mRNA using Superscript III reverse transcriptase following a 
well-established protocol. cDNA was purified using Qiagen PCR purification minispin columns. 
OPN mRNA levels were measured by amplification of cDNA using an Applied Biosystems 
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thermocycler with primers specific for mouse OPN (QuantiTect Primers, Qiagen, and SYBR green 
dye. Copy numbers were calculated by the instrument software from standard curves of genuine 
templates. Standards were previously made by amplifying murine aortic OPN PCR products and 
calculating the copy number based on the concentration and amplicon length of the OPN gene. 
OPN copy numbers were normalized per million copies of the housekeeping gene 18s. 
 
Statistics 
All results are presented as mean ± SEM and analyzed using ANOVA or t-test using 
GraphPad TM Prism Software (GraphPad Prism), followed by Bonferroni or Tukey multiple 








Angiotensin-II (AngII) and Norepinephrine (NE) Increase Systolic Blood Pressure 
            We used two distinct vasoactive agents to induce hypertension in C57BL/6 mice – AngII 
and NE. We used mini-osmotic pumps to continuously infuse AngII (0.75mg/kg/day) or NE 
(5.6mg/kg/day) for seven days. This time point was used as it captures the earliest stages of aortic 
inflammation and remodeling with hypertension [81, 133].  
             We measured systolic blood pressure (SBP) in these mice using tail-cuff plethysmography 
prior to and after infusion of AngII or NE and this is shown in Figure 4.1. We observed a significant 
increase in SBP in mice treated with either AngII or NE. AngII treated mice had a mean SBP of 
169  4 mmHg, with a 51% increase over untreated wild-type controls (WT) controls. Similarly, 
NE treated mice had a mean SBP of 149  4 mmHg, and a 32% increase in SBP compared to WT 
mice. Interestingly, we noticed a much more significant increase in systolic blood pressure with 




Figure 4.1: Continuous Infusion of AngII or NE for 7 days Significantly Increase Systolic 
Blood Pressure There was approximately a 51% and 32% increase in systolic blood pressure with 












































Angiotensin-II (AngII) and Norepinephrine (NE) Increase Osteopontin (OPN) mRNA and 
Protein Expression in Whole Aortas 
 Following 7 days of treatment with AngII or NE and measurement of systolic blood 
pressure, whole aortas (including both thoracic and abdominal regions) were excised and cleared 
of excessive perivascular adipose tissue. We first measured OPN mRNA levels in these aortas 
using quantitative real-time polymerase chain reaction (qRT-PCR). We observed a significant 
increase in OPN mRNA levels in aortas from animals treated with AngII (approximately 8-fold 
increase) and a trending increase with NE treatment (around 1.6-fold increase) compared to their 
WT controls as seen in Figure 4.2. Furthermore, AngII treated aortas expressed almost a 2.2-fold 
higher level of OPN mRNA expression compared with NE treated mice, suggesting that AngII 
may play an even more potent role in eliciting an inflammatory response within the vasculature as 
compared with NE. Interestingly, this increase in OPN mRNA expression with AngII treatment 
follows the same trend as observed with the increase in SBP in AngII treated mice (see Fig 4.1), 
further suggesting a possible synergy between elevated mechanical wall strain due to hypertension 
and AngII alone, although this remains to be further explored. 
Analysis of OPN protein in aortic tissues was analyzed via Western blotting and results are 
shown in Figures 4.3 and 4.4. It was revealed that OPN protein expression was significantly 






Figure 4.2: OPN mRNA expression is upregulated in aortas of mice treated with AngII for 7 
days Real time PCR quantification of OPN mRNA, followed by normalization with a million 
copies of the 18s housekeeping gene was performed on samples from aortas obtained from mice 
infused for 7 days with AngII and NE. OPN expression is upregulated from baseline in both AngII 
and NE treated groups, but there is statistically significant differences only in the AngII treated 
group. AngII treated aortas have significantly higher OPN mRNA compared with NE treated 












Figure 4.3: 7 day AngII Infusion Increases OPN Protein Expression in the Aorta OPN protein 
expression in the aorta of mice was measured following 7 days of both AngII infusion using 
Western Blot Analysis. A significant increase in OPN protein expression was observed in AngII 








































Figure 4.4: 7 day NE Infusion Increases OPN Protein Expression in the Aorta OPN protein 
expression in the aorta of mice was measured following 7 days of both NE infusion using Western 
Blot Analysis. A significant increase in OPN protein expression was observed in NE treated mice 
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Osteopontin (OPN) Protein Expression is Primarily localized to the Medial Layer with 
Hypertension 
Motivated by the differences observed in both OPN mRNA using RT-PCR (Fig 4.2) and 
protein observed using Western Blot analysis (Figs 4.3-4.4), we used immunohistochemistry, to 
identify differences in the expression pattern and localization of OPN with both AngII and NE 
treatment. First, it was observed that OPN expression is almost entirely absent in WT, healthy 
baseline aortas, as very little to almost no red fluorescence intensity (specific to OPN protein) was 
observed (Fig 4.5, panel a). Secondly, we observe that both AngII and NE treatment induce a 
dramatic increase in OPN expression (Fig 4.5, panels b and c). Third, we observe that medial 
thickness is increased and OPN expression appears to be much higher in the AngII treated aortas 
(Fig 4.5, panel b) compared with NE treated aortas (Fig 4.5, panel c), once again suggesting the 
more potent role that AngII plays in mediating both the SBP and inflammatory responses of the 
aortic wall. Finally, we observe that OPN expression is primarily localized to the medial layer of 
the aorta – suggesting that the primary site of expression of OPN was from the smooth muscle 
cells of the media (Fig 4.5). The medial layer of the aorta is primarily responsible for withstanding 
and responding to the cyclic mechanical strain associated with blood flow due to systole and 
diastole, and hence it is not surprising to observe that with elevated blood pressure, the SMCs of 
the medial layer respond by upregulating the expression of OPN protein, which could ultimately 
lead to the adaptive or maladaptive remodeling of the vessel wall. Differences in medial thickness 







Figure 4.5: OPN expression was Increased with Hypertension and Localized Primarily to the 
Media OPN expression in SMCs of the aorta in mice after 7-day AngII and NE infusion compared 
to WT control as measured by immunohistochemistry. RED=OPN, BLUE=DAPI. Representative 
images are shown and were taken at 10X for an N=4 
   
a. WT 
b. AngII c. NE 
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Hydrogen Peroxide Scavenging Mediated by Catalase Blunts Increased OPN expression 
with Hypertension in Murine Aortas 
So far we have investigated the differences in OPN expression in wild-type (WT) baseline 
and hypertensive aortas.  We next wanted to determine if catalase-mediated scavenging of H2O2 
produced specifically in vascular smooth muscle cells protects the aorta against this hypertension 
related increase in pro-inflammatory OPN expression.   Hence, we treated transgenic mice with 
smooth muscle cell (SMC)-specific catalase overexpressing (TgSMC-Cat) and WT animals with 
AngII or NE for 7 days. We observed a significant increase in blood pressure in both strains of 
mice with both treatments (Fig 4.6). This result indicated that blood pressure was not affected at 
baseline with overexpression of catalase, but with hypertensive stimuli such as AngII and NE, 
blood pressure was increased similarly in these TgSMC-Cat, just as is observed in WT mice.  
Finally, we measured OPN protein levels using Western Blot analysis in these aortas at 7 
days post infusion with AngII or NE. We observed that there was a significant increase in OPN 
expression in the WT mice with either AngII or NE expression (Fig 4.7) as was already previously 
seen (Figs 4.3-4.5), but there was a dramatic blunting of OPN expression in the aortas of the 
catalase overexpressing (TgSMC-Cat) mice (Fig 4.7). Our results show that reducing H2O2 production 
in the medial layer of the aorta imparts a protective environment against the inflammatory increase 
in OPN expression. This result is further supported by other studies from our group that have 
shown protection of the aorta against the inflammatory effects of hypertension. For example, 
transgenic catalase overexpressing mice have been shown to be protected against vascular 
hypertrophy with hypertension induced by 14 days of AngII infusion [81]. Furthermore, it has 
been shown that both pharmacologic infusion and genetic overexpression of catalase protected 






Figure 4.6: Systolic Blood Pressure is Increased in both WT and Transgenic Catalase 
Overexpressing Mice in both models of hypertension Systolic blood pressure was measured in 
catalase overexpressing and wild type (WT) mice at baseline and following 7 days of AngII or NE 































































Figure 4.7: Hypertensive Smooth Muscle Cell Catalase overexpressing mice (TgSMC-Cat) 
showed attenuated OPN levels OPN protein was measured using Western Blot analysis in 
aortas from WT and TgSMC-Cat mice made hypertensive using 7-day AngII and NE infusion for 












































For this aim, we used two murine models of hypertension and an existing strain of mice 
that overexpress catalase specifically within vascular smooth muscle cells. We hypothesized that 
increased oxidative stress, specifically related to increased hydrogen peroxide, led to aortic 
inflammation by upregulation of the pro-inflammatory protein, osteopontin (OPN). We tested this 
hypothesis by analyzing levels of OPN mRNA and protein at baseline and with hypertension. We 
also histologically analyzed expression of OPN within the aorta after inducing hypertension. 
Finally, we measured OPN protein expression with hypertension utilizing the transgenic catalase 
overexpressing mice (TgSMC-Cat). Overall the results of this aim demonstrate that H2O2 indeed alters 
inflammation of the aorta by regulating the expression of OPN in the setting of hypertension.  
Specifically, we have shown that: 
a) hypertension-related stimuli (whether humoral or mechanical) can lead to a direct 
increase in pro-inflammatory protein expression 
b) the medial layer of arteries plays an important role in sensing and responding to 
changes in the mechanical milieu, especially in relation to hypertension  
c) catalase which is an antioxidant against H2O2, plays a pivotal role in protecting arteries 
against pro-inflammatory stimuli in response to hypertension 
It has been shown that OPN levels are increased in blood plasma of hypertensive human 
subjects [146]. Early studies exploring the role of OPN in the vasculature have shown that it plays 
an important role in accelerating AngII-dependent atherosclerosis and aneurysm formation [146]. 
OPN was further proven to play an important role in mediating the recruitment of macrophages to 
the arterial wall in the setting of AngII-mediated inflammation in the aorta [146].  Isoda et al have 
also shown that overexpression of OPN in the vasculature is related to a significant increase in 
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medial thickening with aging and neointimal formation with arterial injury [110]. However, the 
mechanism by which hypertension is related to OPN is still unknown.  
Our results from Chapter 3 suggest that mechanical strain indeed leads to an increase in 
OPN expression in-vitro. We also show in this aim that OPN is upregulated in the aorta through 
the use of two independent humoral factors (namely AngII and NE) and that both cause an increase 
in blood pressure (Fig 4.2-4.5). This suggests that elevated vascular wall strain due to hypertension 
may in fact be the common stimulus responsible for increased OPN and ultimately the progression 
of inflammation in the aorta. However, delineating the independent effects of humoral versus 
mechanical factors on inflammation in the aorta with hypertension are impossible to clarify using 
an animal model alone, and call for further in-vitro and in-vivo studies, or a combination thereof.  
Some of the other models of hypertension that maybe utilized in future studies to further 
clarify the role of humoral and mechanical factors in regulating OPN expression. The aortic 
coarctation model used by Ollerenshaw et al involved the creation of an aortic stenosis of constant 
diameter by the tying of a silk ligature between the origins of the two renal arteries [57]. This 
coarctation induced a region of high blood pressure above the coarctation and normal blood 
pressure, below [57]. Some of the results of this study have already shown that there was a 
significant increase in the medial thickness of the aorta above the coarctation at 9 and 20 days post 
procedure [57]. Analysis of OPN expression above and below the coarctation would provide a 
better understanding on the specific role of elevated mechanical strain on OPN expression.  
The two-kidney, one-clip model of hypertension developed by Goldblatt et al. is another 
model that maybe used to study the effects of a gradual and chronic increase in blood pressure on 
the aorta. However, the increase in blood pressure induced by this model maybe influenced by 
changes to components of the RAAS system (such as renin and angiotensin), and therefore 
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delineating the effects of humoral versus mechanical signals maybe more challenging, if utilizing 
this model.  
Furthermore, continuous infusion of both AngII and NE for 7 days does increase blood 
pressure, although AngII alone seems to increase blood pressure significantly more compared with 
NE (Fig 4.1). This observation is supported by a previous study that showed that mean arterial 
pressure was higher in carotid arteries of animals treated with AngII as compared with NE [147].  
In addition to having a more potent effect on blood pressure, we also know that AngII can 
have an independent effect on OPN expression in SMCs [130]. The studies performed by Remus 
et al have shown that OPN mRNA and protein expression are significantly increased in SMCs with 
24 hours of treatment with 100nM of AngII [130]. However, the effect of NE alone on OPN 
expression in SMCs is yet to be identified. Finally, it is important to note that both humoral and 
mechanical factors are most likely working synergistically towards causing inflammation of the 
aorta, and therefore, the combined effects of these factors ought to be critically analyzed in future 
studies.  
AngII is known to increase blood pressure via several actions – namely vasoconstriction, 
sympathetic nervous stimulation, and increased aldosterone production [148]. AngII acts mostly 
via G-protein coupled receptors – namely - AT1 or AT2 receptors [149] The AT1 receptor (AT1R) 
is known to primarily mediate all the classically known physiological actions of AngII. These 
receptors are expressed by numerous cell types and organs ranging from kidney, vascular and 
immune system, adrenal, heart, and both peripheral and central nervous system [149]. In the 
kidney, activation of AT1R by AngII leads to increased sodium reabsorption and renal 
vasoconstriction [144, 149].  In the vasculature, AT1R is known to increase peripheral resistance 
and induce vasoconstriction [144].  
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AngII binding to AT1 receptors on the membrane of cells is known to cause the dissociation 
of G-coupled protein receptors (GPCRs) [150]. This dissociation is typically related to the 
intracellular loops of the receptor, activation of the phospholipase C (PLC), cleavage of 
phosphoinositides to form inositol triphosphate (IP3) and diacylglycerol (DAG) [150]. IP3 then 
causes the release of calcium ions from intracellular Ca stores, while activated AT1 receptors also 
cause cause calcium channels to open within the cell membrane [150].  
Norepinephrine (NE) is released by the sympathetic nervous system and adrenal medulla. 
Typically, NE released by the sympathetic nervous system is taken up by the nerves [151]. 
However, at times of high sympathetic nerve activation, there is a dramatic increase in the 
concentration of NE in the bloodstream as well. NE causes a significant transient increase in heart 
rate and contractility via 1 adrenoceptors [151]. It also causes significant vasoconstriction in 
arteries via 1 and 2 adrenoceptors [151]. The overall response to NE in the cardiovascular 
system is an increase in blood pressure, via increases in cardiac output and systemic vascular 
resistance [151].  
The three 1 receptors are coupled to the Gq pathway, that stimulates phospholipase C 
(PC) and generates the second messengers inositol (1, 4, 5,) – triphosphate (IP3) and diacylglycerol 
(DAG), which mobilizes intracellular calcium ions, activates protein kinase C (PKC), and in some 
tissues activates sodium-hydrogen, sodium-calcium exchangers, or potassium channels [150]. The 
three 2 adrenergic receptors couple to the Gi receptor, which inhibits cyclic adenosine 3’, 5’-
monophosphate (cAMP)-dependent protein kinase A (PKA) [150]. Finally, the -AR subtypes are 




Studies in the 1990s showed that OPN was synthesized by smooth muscle, endothelial 
cells, and macrophages in human primary and restenotic coronary atherosclerotic plaques [152]. 
Work by O’Brien et al have shown that OPN mRNA and protein were abundant in human primary 
and restenotic coronary artery lesions, but almost undetectable within the intima or media of non-
diseased coronary arteries [152]. We observe similar patterns from the histological results of this 
aim. We see that OPN expression is almost undetectable in the media or intima of the aortic cross-
sections of healthy, WT mice (Fig 4.5, panel a). However, there is a dramatic increase in OPN 
expression, primarily localized within the medial layers of the aorta with AngII and NE treatment. 
It is interesting to note that the pattern of increase in OPN expression within the aortic cross 
sections (Fig 4.5) is similar to the pattern of increase in systolic blood pressure with AngII or NE 
treatment (Fig 4.1). These observations lead us to speculate that the medial layer is sensitive to 
and responds to changes in vascular wall strains as a result of varying blood pressure. 
Literature suggests that the healthy aorta experiences a circumferential strain of about 10-
15% [153, 154]. In this aim, we observed that the healthy aorta in-vivo had very little to almost no 
OPN expression at baseline (Fig 4.5), but our results from Aim 1 show that SMC’s exposed to 
10% strain in the stretch device, get a very robust upregulation of OPN expression (Fig 3.4-3.7). 
These results at first appear to be in contradiction to each other, however, a closer look reveals that 
these differences maybe attributed to the known differences in properties of SMCs within the aorta 
in-vivo, and those grown in culture. It is known that SMCs often exist on a spectrum of 
intermediate morphologies, in which contractile and synthetic SMCs, represent the two ends [155]. 
Contractile SMCs often have a spindle-shaped and elongated morphology, whereas synthetic 
SMCs have a cobblestone morphology [155]. Synthetic SMCs contain a large number of 
organelles involved in protein synthesis, and exhibit faster growth and migratory rates [155]. In 
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the healthy aorta, SMCs tend to have more of a contractile phenotype, however, when cultured the 
levels of contractile protein makers are known to gradually decrease [156]. In our studies, SMCs 
grown in culture tend to have features similar to that of synthetic SMCs, which is why they are 
quiesced under serum free conditions prior to experiments, in order to better assess the response 
and behavior of SMCs to various stimuli.  
Physical factors are also known to have a significant impact on the phenotypic modulation 
of SMCs. It is known that mechanical forces such as circumferential strain increase the expression 
of ECM and contractile phenotype in SMCs of blood vessels [155], and this constant exposure to 
mechanical strain maybe a reason why OPN expression was present at low concentrations in the 
healthy aorta. Quiesced, non-strained, SMCs grown in culture had a similar phenotype and 
expressed low levels of OPN as well. However, upon exposure of these quiesced, SMCs to 
mechanical strain increased OPN expression, suggesting that a change to the mechanical strain 
environment experienced by these SMCs in-fact induces the expression of pro-inflammatory 
proteins including OPN.  
ROS-mediated inflammation of arteries has been well established in literature, in the 
setting of a plethora of cardiovascular disease pathologies. Several studies have delved into 
elucidating the specific role of H2O2 in mediating inflammatory processes. Of specific interest to 
this project, we note that several studies demonstrate that H2O2 mediates abdominal aortic 
aneurysm (AAA) formation through the use of the TgSMC-Cat mouse model [133, 145]. A 
remarkable decrease in aortic dilatation, MMP activity, and SMC apoptosis was observed in 
TgSMC-Cat aortas compared with WT mice following treatment with CaCl (used in order to induce 
AAA) [145]. Another study demonstrated that TgSMC-Cat following AngII treatment had better 
protected mechanical properties and altered matrix protein expression leading to a complete 
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absence of AAA incidence [133]. These studies highlight the vital role of H2O2 in mediating 
inflammation within the vasculature.  
Another relevant observation from a previous study has shown that both WT and TgSMC-Cat 
treated with AngII for 14 days exhibit a significant increase in systolic blood pressure and vascular 
hypertrophy [81]. We observe similar results in both murine groups with 7 days of AngII and NE 
treatment suggesting that 1) blood pressure goes up as early as 7 days, and that 2) TgSMC-Cat mice 
are sensitive to both AngII and NE treatment by responding with elevated systolic blood pressure. 
Finally, it is known that aortic segments from TgSMC-Cat mice have a significant attenuation in H2O2 
levels with AngII treatment compared with WT aortic segments [81]. This attenuation in H2O2 
with hypertension in the aorta may be the primary reason for the blunted increase in OPN 
expression we observed in both the AngII and NE treated TgSMC-Cat mice as seen in Fig 4.7. These 
data reveal a definite mechanistic link between H2O2 and OPN. This observation is further 
corroborated by published work of Lyle et al. Some of the in-vitro data show that OPN is 
upregulated over a time course of 24 hours and with varying doses of H2O2 treatment [7].  This 
work suggests that increases in OPN expression in response to H2O2 occur at early time points via 
translational modifications, and at later time points via transcriptional changes. It was also shown 
that OPN expression was decreased in the setting of hind-limb ischemia in TgSMC-Cat mice as 
compared with WT mice [114]. 
Taking all our results from Aim 2, we have shown in summary that: 
1) AngII and NE-dependent hypertension upregulates OPN mRNA and protein 
expression in the aorta 




3) Overexpression of catalase, which is an antioxidant against H2O2, protects the aorta 
against the pro-inflammatory increase in OPN. 
These data provide evidence that H2O2 plays a pivotal role in mediating hypertension-
related inflammation within the vasculature, and this link might be critical in developing effective 
preventative and therapeutic strategies in the treatment and management of hypertension related 





EXPLORING THE ROLE OF OSTEOPONTIN IN AORTIC BIOMECHANICS WITH 
HYPERTENSION 
SPECIFIC AIM 3: 
To determine the contribution of osteopontin to the mechanical properties of the aorta at baseline 
and in the setting of hypertension  
Introduction 
 The aorta plays an important role in the transportation and collection of blood from various 
organs and tissues of the body. The material components that provide primary structure to the aorta 
include endothelial and smooth muscle cells, elastin, and collagen [157, 158]. The mechanical 
behavior of the aorta is clearly linked to its material composition. There is significant alteration to 
the material environment of the aorta in the setting of hypertension. These changes are mediated 
by the cellular components of the aorta that sense changes in mechanical strain and stress. These 
responses to hypertension, within the aorta, lead to its growth and remodeling, which ultimately 
translates to altered physiologic or pathophysiologic mechanical behavior.  
When the healthy aorta is isolated, it typically undergoes a reduction in its diameter by 
20% and length by around 40%, indicating that the cellular and protein components of the aorta 
are typically under tension [14]. Blood pressure within the aorta induces further strain of about 10-
20% [15]. These pre-stresses and strains indicate that under physiological conditions, the aorta 
operates in the high strain region of its stress-strain curve [13, 15].  
In the setting of hypertension, changes in material or structure in response to the altered 
stresses and strains begin at the cellular level [41, 159]. The existing body of literature suggests 
that with hypertension, smooth muscle cells first hypertrophy, proliferate, and produce excess 
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ECM proteins, which ultimately leads to a thickened and stiffer vessel wall that allows intramural 
stresses to return toward normal values [160-163]. Some of the geometric and mechanical 
parameters that highlight the mechanical behavior of the aorta and that are explored in this chapter 
include thickness of the vessel wall, aortic diameter under varied intramural pressures, and local 
compliance. Compliance measurements reflect upon the ability of the aortic wall to expand with 
varying levels of intraluminal pressure and are closely linked to and controlled by the vessel 
geometry and composition. We further explored the microstructure and material composition of 
the aorta by histological analysis of proteins such as collagen and elastin.  
 A key player and mediator of vascular pathophysiology that has recently emerged in 
literature, is the matricellular protein, osteopontin (OPN). It is known that OPN mediates AngII-
induced vascular hypertrophy, and is a potent chemoattractant for macrophages and leukocytes, 
that could bring in extra-cellular matrix degrading enzymes, such as matrix metalloproteinases 
(MMPs). It’s role in mediating hypertrophy and inflammation within the aorta, led us to 
hypothesize that the lack of OPN in mice may alter the biomechanics of the aorta, with 
hypertension. We also observed in Chapter 4 that OPN is significantly upregulated in the setting 
of disease hypertension within the aorta, however, it is unknown whether OPN alters the 
mechanical properties of the hypertensive aortic wall. In this chapter, therefore, we utilize OPN 
knockout (KO) mice and explore changes in the material, geometric, and mechanical parameters 
under baseline and angiotensin-II-induced hypertensive conditions. We only used the AngII model 
of hypertension for this aim, however, future studies should consider other models of hypertension 
as well, including NE infusion, for a thorough analysis of the effects of the lack of OPN on 






Eight to twelve week old male C57BL/6 (WT) mice or OPN Knockout (KO) mice were 
purchased from Jackson Laboratories (Bar Harbor, ME). The animals were housed and cared for 
according to the guidelines approved by the Emory University Institutional Animal Care and Use 
Committee (IACUC). 
 
Osmotic Minipump Implantation 
Mice were anesthetized using 1% isofluorane (oxygen delivered at 0.5L/min with 2% 
isofluorane for induction and 1% isofluorane for maintenance). AngII (Sigma Aldrich, A6402) at 
a dose of 0.75mg/kg/day was infused via a primed mini-osmotic pump (Alzet mini-osmotic pump, 
Model 2004). The pumps were inserted subcutaneously, on the back. Following surgery, mice 
were administered buprenex (1mg/kg, SC), once prior to surgery, and then as needed.  
 
Measurement of Systolic Blood Pressure 
Mice were first acclimatized to the tail-cuff plethysmograph (Visitech© Corporation) for 
at least three consecutive days. Systolic blood pressure was then measured prior to and after 
infusion of AngII.  
 
Measurement of Aortic In-Vivo Length, Aorta Isolation, and Preparation 
 Mice were first euthanized via CO2 asphyxiation. The thoracic cavity was opened and the 
aorta cleared of excessive connective tissue. Prior to excision, a small ruler was placed beside, and 
at the same focal plane as that of the aorta. An image of the intact aorta and ruler was taken using 
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a dissection microscope camera. This image was then opened in Image J, and a conversion factor 
(for pixels-to-mm) generated, based on the distance between two tick marks (1mm) on the ruler. 
A straight line was drawn from the start of the descending aorta until the end of the thoracic aorta 
(near the celiac trunk). The distance of this line was then calculated by Image J, based on the 
previously generated pixel-to-mm conversion factor, and is approximately the in-vivo length of the 
aorta.  
After excision, the fatty tissue surrounding the aorta was carefully removed. Care was taken 
to make sure that the intercostals, celiac trunk, mesenteric and renal arteries were left still attached 
to the aorta. Following the removal of fat, the intercostals and remaining branches were tied off 
with silk suture filaments, each fastened away from the surface of the aorta to prevent the knots 
from interfering with the expansion of the aorta under pressurization. During cleaning and the 
course of the experiments, the aorta was maintained in sterile 1X PBS with a pH of 7.4.  The region 
of the aorta being tested was the thoracic region. 
 The aorta was then cannulated onto a 200m diameter glass cannula in a multiaxial 
computer-controlled vessel isolation device similar to one that has been previously described 
[164]. The aorta and cannula were suspended into a bath containing 1X PBS and 10M sodium 
nitroprusside (SNP) to ensure that the aorta was fully dilated during the testing process. The aorta 
was perfused through the two glass cannula which allows for the precise control of the luminal 
pressure. These cannulae are attached to two computer controlled linear motion actuators that can 
allow for the careful control of the vessel length during the mechanical test. The device was placed 
above an inverted microscope and real time images of the aorta acquired at a magnification of 2.5x 
in a temperature controlled incubator. The device allows for the precise maintenance of 
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intraluminal pressure and axial length of the aorta, while simultaneously recording the outer 
diameter of the vessel. 
 
Mechanical Testing of Aortas 
Following cannulation, the unloaded length of the aorta was first measured and the vessel 
was then preconditioned. Fixed length pressure-diameter tests were then performed at varying 
axial stretches () ranging from =1.3, 1.4, 1.5, 1.6, 1.7, 1.8, and 1.9. Here axial stretch, , is 
defined as the ratio of the loaded vessel length to the unloaded vessel length. During the pressure-
diameter tests, the aorta was inflated from 10mm to 200mm Hg at the axial stretches previously 
listed and the outer diameter of the aorta continuously recorded, with two loading and unloading 
cycles for each axial stretch. 
 
Pressure-Diameter (P-D) Curves and Compliance Analysis 
Following mechanical testing, pressure-diameter (P-D) curves were generated from the 
raw data obtained from the device. The P-D curves for all aortas followed a biphasic trend that 
include regions of low deformation under low pressures, a linear increasing region under mid-
range pressures, and finally a flat deformation plateau at peak pressures.  
Local compliance of the aortas was calculated at 20mmHg increments to generate pressure-
dependent compliance versus pressure curves. A linear trend line was applied to the pressure-
diameter curves 10mm Hg above and below an indicated pressure in order to obtain local 






Following mechanical testing, aortas were fixed with 10% buffered formalin. Aortas were 
then paraffin embedded and cut into 5 µm increment sections. Sections were then stained with 
hemotoxylin and eosin (H&E) for analysis of gross aortic morphology, Verhoff’s van Geison 
Elastic Stain for elastic laminae, and Masson’s Trichrome Stain for collagen. Medial thickness, 
elastin interlamellar gap, and length of the aorta were calculated using Image J Software. 
 
Statistics 
All results are presented as mean ± SEM and analyzed using ANOVA or t-test using 
GraphPad TM Prism Software (GraphPad Prism), followed by Bonferroni multiple comparisons 





Systolic Blood Pressure is Increased in Both WT and OPN KO Mice with Angiotensin-II 
Treatment 
             We used mini-osmotic pumps to continuously infuse AngII (0.75mg/kg/day) in both wild 
type (WT) and OPN KO mice. We measured systolic blood pressures (SBPs) in WT mice at 
baseline and WT mice that were infused with AngII for three, seven, and fourteen days. We also 
measured SBPs in OPN KO mice at baseline and in those infused with AngII for seven days.  
            We observed a significant increase in SBP in WT mice treated with AngII at all three time 
points – three, seven, and fourteen days compared to the baseline WT controls (Fig 5.1). Three 
day AngII treated mice had a mean SBP of 152  7 mm Hg, with a 41% increase over baseline 
WT, while seven and fourteen day AngII infused mice had a mean SBP of 161  4 mmHg and 171 
 3 mmHg, with a 49% and 59% increase over baseline WT controls, respectively. These increases 
were statistically significant. 
 OPN KO mice had a baseline SBP of 114  2 mmHg, and when treated with 






Figure 5.1: Systolic Blood Pressure is Significantly Increased in both WT and OPN KO mice 
with AngII infusion Baseline SBPs were similar in both WT and OPN KO mice. There was a 
significant increase in SBP in WT treated with AngII for 3, 7 and 14 days, and also in the OPN 






















































































In-Vivo Aortic Length Is Not Altered with Angiotensin-II Treatment in WT or in OPN null 
mice 
            To determine whether there was any difference in the axial environment of the aorta in-
vivo, we measured the length of the aorta while still intact and inside the animal. We observed no 
significant differences in the in-vivo length of the aorta among all treatment groups, reflecting that 
there are no alterations to the axial environment or tension of the vessel. The in-vivo length of the 
aorta was measured via Image J analysis as previously mention and the average length of the aorta 
(thoracic and suprarenal region) was 19.5  0.5mm among all treatment groups (Fig 5.2). We 
further determined the in-vivo stretch needed for mechanical testing based on the ratio between 
this calculated in-vivo length and the unloaded ex-vivo length of the excised aorta. The in-vivo 






Figure 5.2: In-Vivo Length of WT and OPN KO Aortas is not Altered with AngII Treatment 
The in-vivo length of the aorta was determined at baseline and with 3, 7, or 14 days of AngII 
treatment in WT mice, and at baseline and with 7 days of AngII treatment in OPN KO mice. No 




































































Angiotensin-II Infusion Increases Aortic Diameter, but does not alter Aortic Compliance 
            We wanted to first determine how AngII-induced hypertension would affect aortic 
mechanics over the time course of 3, 7, or 14 days. The P-D curves (Fig 5.3) demonstrated a 
biphasic behavior which reflects reduced vessel expansion at lower pressures and stiffening at 
higher pressures. We observe a significant increase in diameter with AngII treatment at low and 
mid-range pressures of 20, 40, and 60 mm Hg. Statistical analysis revealed that there was no 
significant change in aortic diameter with three days of AngII treatment at all pressures compared 
with the baseline WT diameters, although there appears to be a trending increase. Seven days of 
AngII infusion, however, induced a significant increase in diameter at 20 and 40 mmHg, while 
fourteen days of AngII infusion induced a significant increase at 20, 40, and 60 mm Hg. This 
increase in aortic diameter suggests that AngII-induced hypertension causes the vessel to remodel 
in order to compensate for the elevated blood pressure as early as potentially three days, and 
definitively by seven and fourteen days. 
          Analysis of the local pressure-dependent compliance (Fig 5.4) obtained by calculating the 
slope of P-D data revealed a bell-shaped curve with minimum compliance observed at low (20mm 
Hg) and high pressures (100mm Hg and higher) and maximal compliance at mid-range pressures 
(40-80mm Hg). However, there was no statistical difference in the compliance properties of these 
aortas with AngII treatment, suggesting that these murine aortas are able to adaptively remodel in 
a robust and rapid manner at time points as early three days lasting up to fourteen days. Further 






Figure 5.3: AngII-induced Hypertension Increases Aortic Diameter Mechanical testing of WT 
aortas treated with AngII for 3, 7, and 14 days revealed a significant increase in vessel diameter at 
the early and mid-range pressures of 20-60mm Hg. Seven day AngII treatment caused an increase 
in diameter at 20 and 40mm Hg (* p<0.05 7d AngII vs WT Baseline), while fourteen day AngII 
treatment increased diameters at 20, 40, and 60mm Hg (* p<0.05 7d AngII vs WT Baseline). N=6 
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Figure 5.4: Pressure-Dependent Local Compliance is not Altered in murine WT aortas with 
AngII Treatment at 3, 7 or 14 days Analysis of local compliance obtained by calculating the 
slope of P-D curves of WT aortas treated with AngII for 3, 7, and 14 days revealed no changes in 
aortic compliance. N=6 for WT Baseline, N=4 for 3d AngII, N=5 for 7d AngII, and N=4 for 14d 




Angiotensin-II Infusion Increases Medial Thickness of the Aorta 
 Representative images of aortic cross sections of aortas obtained from baseline WT mice 
and WT mice treated for three, seven, and fourteen days with AngII are shown in Figure 5.5. The 
images reveal that the baseline WT aortic wall (Fig 5.5, top left panel) comprises of 4-5 concentric 
elastic lamellae as shown by H&E Stain. The medial thickness of the aorta is significantly 
increased with AngII treatment for three, seven, or fourteen days as compared to the baseline WT 
mice aortic cross sections (quantified in Fig 5.6). Another notable difference is the presence of a 
thicker adventitial layer that reveals infiltration of inflammatory cells and abundance in collagen 
in the seven and fourteen day AngII treated samples (Fig 5.5, bottom left and right panels) as 
compared to the baseline WT or three day treated samples.  
 Finally, the medial layer of the aortic wall appears to have uniformly thickened with AngII 
treatment, suggesting that these aortas have all adaptively remodeled. Furthermore, we do not 
observe any elastin breaks or separation in the layers of the aortic wall, and the aortic wall appears 
to be relatively intact in all treatment groups. These observations provide evidence in support of 
our previous observation that shows no change in the compliance properties of aortas treated with 
AngII for three, seven, or fourteen days, suggesting that they have all successfully adaptively 







Figure 5.5: Medial Thickness is Increased with 3, 7, or 14 day AngII infusion Representative 
images reveal aortic microstructures of samples obtained from WT mice at baseline or treated 
with AngII for 3, 7, or 14 days and stained with hemotoxylin and eosin (H&E). We observe a 










Figure 5.6: Medial Thickness of Aorta Increases with AngII Treatment We observe a 
significant and stepwise incremental increase in medial thickness of the aorta with treatment with 

















































Aortic Diameter and Compliance is Altered in OPN null mice 
            Osteopontin (OPN) is an important mediator of arterial inflammation and remodeling in 
response to ischemia and injury [113, 114, 140]. However, it is unknown if OPN mediates arterial 
remodeling in response to hypertension. In order to determine its potential role, we used OPN null 
mice and treated them with AngII for 7 days, which is the earliest time point we observe changes 
in the mechanical behavior of the aorta (Fig 5.3).  
              The P-D curves obtained from OPN KO mice (Fig 5.7) revealed a biphasic behavior 
similar to the WT mice which reflects reduced vessel distension at lower pressures and stiffening 
at higher pressures. However, the most surprising observation was that OPN KO mice have 
significantly higher aortic diameters at all pressures (low, mid-range, and high) at both baseline 
conditions and when treated with AngII.  Seven days of AngII infusion increases outer aortic 
diameter at 20 and 40 mmHg as was already previously noted (Fig 5.3).  
        We analyzed local pressure-dependent compliance curves of OPN KO mice (Fig 5.8) 
obtained by calculating the slope of P-D data and it also revealed a similar bell-shaped curve with 
minimum compliance observed at low (20mm Hg) and high pressures (100mm Hg and higher) 
and maximal compliance at mid-range pressures (40-80mm Hg). We observed that OPN KO aortas 
at baseline had a statistically higher compliance at the mid-range pressure of 60mm Hg compared 
with baseline WT aortas (10.3  0.4 versus 8.02  0.39 mm/mm Hg, respectively). OPN KO aortas 
treated with AngII had significantly lower compliance at 60mm Hg compared with OPN KO 
baseline aortas (8.70  0.53 versus 10.3  0.4 mm/mm Hg, respectively). Therefore, the results of 
these mechanical tests reflect that OPN does indeed have an impact on the mechanical properties 
of the aorta. Evaluation of the microstructure through histological analysis provide further 





Figure 5.7: OPN KO Aortas Have Dramatically Higher Aortic Diameter with and without 
AngII treatment Mechanical testing of OPN KO and WT aortas at baseline conditions and treated 
with AngII for seven days revealed significantly higher vessel diameters at all pressures. OPN KO 
aortas at baseline had significantly higher diameters at all pressures except 160mm Hg (Blue * 
p<0.05 OPN KO Baseline vs WT Baseline). Seven day AngII treated OPN KO mice had elevated 
diameters at all pressures (Black * p<0.05 OPN KO Baseline vs WT Baseline). Finally, seven day 
AngII treated WT aortas have increased diameters at 20mm Hg and 40mm Hg (Red* p<0.05 7d 
AngII vs WT Baseline). N=6 for WT Baseline, N=5 for WT + 7d AngII treated mice, N=5 for 
OPN KO Baseline, and N=6 for OPN KO + 7d AngII treated mice. 
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Figure 5.8: OPN KO aortas have Higher Maximal Compliance than WT aortas Mechanical 
testing of OPN KO and WT aortas at baseline conditions and treated with AngII for 7 days revealed 
a significant increase in compliance in OPN KO aortas. OPN KO aortas at baseline had greater 
local compliance at 60mm Hg compared with both WT baseline and OPN KO aortas treated with 
AngII (Blue * p<0.05 OPN KO Baseline vs. WT Baseline). N=6 for WT Baseline, N=5 for 7d 
AngII treated WT mice, N=5 for OPN KO Baseline, and N=4 for OPN KO + 7d AngII treated 
mice. 
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Osteopontin KO Aortas Have Altered Microstructural Features and are Protected against 
Inflammatory Infiltration with Hypertension 
 Representative images of aortic cross sections from WT and OPN KO mice treated with 
seven days of AngII are shown in Figure 5.9. We observe differences between WT and OPN KO 
aortas even under baseline conditions. These OPN KO aortas appear to have a moderate increase 
in medial thickness as compared to WT aortas (Fig 5.9 top left and bottom left panels). However, 
this difference may be attributed to the difference in elastin fiber structure and organization in the 
OPN KO. We observe that baseline OPN KO aortas appear to have elastin fibers that are straighter 
and more widely spaced (Fig 5.11, top left and bottom left panels). On the other hand, baseline 
WT aortas have elastin lamellae that are wavier, more undulated, and tightly spaced (Fig 5.11, top 
left and bottom left panels). This inter-lamellar elastin gap is quantified in Figure 5.12.  
 As was previously noted in Figure 5.5 and 5.6, medial thickness is significantly increased 
in WT mice treated with AngII for seven days (Fig 5.9-5.10). These hypertensive WT mice also 
have a thickened adventitia abundant in collagen and inflammatory cells (Fig 5.9-11, top right). 
Interestingly, we observe an increase in medial thickness in AngII-treated OPN KO mice, but these 
aortas do not have a thick adventitial layer, abundant in collagen, suggesting that these mice are 







Figure 5.9: Hypertensive OPN KO mice are Protected against Adventitial Inflammation 
Representative images reveal aortic microstructures of samples obtained from WT mice and OPN 
KO mice at baseline or treated with AngII for seven days stained with H&E. OPN KO aortas 
appear to have a slightly increased medial thickness due to widely spaced elastin fibers, that also 
appear to be more unfolded as compared to the elastin in WT aortas. There is also significantly 
greater thickening of the adventitia in the WT mice treated with AngII compared with the OPN 















Figure 5.10: AngII Infusion Induces Medial Thickening in Both WT and OPN KO aortas 
Treatment with 7 days of AngII significantly increased medial thickness in both WT and OPN KO 
aortas. There also appears to be an increase in medial thickness of baseline OPN KO aortas. 



































































Figure 5.11: OPN KO Aortas Have Altered Elastin Organization WT and OPN KO aortas 
were stained with Verhoff’s van Geisson to identify differences in elastin organization. We 
observe that the elastin lamellae in baseline WT aortas (top left) appear more undulated, wavy, 
and closely spaced, while those in the baseline OPN KO aortas (bottom left) appear to have 
straighter fibers and more widely spaced organization. 7-day AngII treatment of both WT and 
OPN KO aortas appears to increase the gap between the elastin lamellae (top right and bottom 













Figure 5.12: OPN KO Aortas Have Increased Elastin Interlamellar Gaps The shortest distance 
between the elastin lamellae at multiple points on the aorta were measured using ImageJ software 
and quantified for the various treatment groups shown in the previous figure. Baseline OPN KO 
and AngII treated WT and OPN KO aortas have greater elastin interlamellar gaps compared with 






























































Figure 5.13: Hypertensive OPN KO have Reduced Adventitial Collagen, Adventitial 
Thickening, and Inflammation Aortic cross-sections were stained with Masson’s Trichrome in 
order identify differences in collagen (stained blue). WT mice treated with AngII for seven days 
(top right) appear to have a striking increase in collagen in the adventitial layer of the aorta as 
compared with baseline WT levels (top left). Interestingly, aortas from OPN KO mice treated with 
AngII for seven days appear to have significantly lower levels of collagen in the adventitia, 
suggesting that it plays a role in mediating adventitial inflammation with hypertension (bottom 
right). N=3 for WT Baseline, N=6 for all other groups. 
 











Figure 5.14: Hypertensive OPN KO have Significantly Reduced Inflammation Aortic cross-
sections were stained to for CD107b (also known as Mac3) in order identify invasion of 
macrophages within the aorta. WT mice treated with AngII for seven days (top right) appear to 
have a striking increase in Mac-3 expression within the aorta as compared with baseline WT levels 
(top left). Interestingly, aortas from OPN KO mice treated with AngII for seven days appear to 
have significantly lower level to almost no expression of Mac-3, suggesting that OPN KO mice 
are protected against AngII-induced inflammation (bottom right). N=3 for WT Baseline, OPN KO 













Osteopontin (OPN) has been shown to play an important role in vascular physiology and 
pathophysiology. While several studies have highlighted its role as a mediator of inflammation 
[95, 165], angiogenesis [7], tumor growth [166], and tissue remodeling, its unique role in 
mediating vascular biomechanics in the setting of hypertension is still unclear. Our initial working 
hypothesis for this aim was that the lack of OPN would contribute to changes in the mechanical 
properties of the aorta only in the setting of hypertension and not under basal conditions. Our 
rationale for this hypothesis was that OPN is almost absent in WT aortas under baseline conditions, 
and therefore, we expected to not observe any mechanical differences in OPN KO aortas under 
baseline conditions as well. Moreover, results from several clinical studies and our findings from 
aims 1 and 2, show that OPN expression is significantly increased only in the presence of a vascular 
insult or elevated mechanical stress.  
To test our hypothesis, we measured pressure versus diameter (PD) and compliance 
behavior of OPN KO and WT aortas under healthy and AngII-induced hypertensive conditions. 
We further characterized the morphology of these aortas via a thorough histological analysis.  
Overall, the results of these studies demonstrate that OPN does indeed significantly change the 
biomechanical properties of the aorta, however, to our surprise this was true under both healthy 
and diseased settings.  
Prior to commencing our studies with OPN KO aortas, we wanted to determine the earliest 
time point at which biomechanical differences in WT aortas are most pronounced with AngII 
treatment. Most studies that have explored hypertension related arterial compliance changes, have 
done so only in human subjects, and have not carefully explored the time scales over which these 
changes occur [167-170]. 
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We therefore performed a time course study, and analyzed PD and local compliance curves 
obtained from aortas of WT mice treated with AngII for three, seven, or fourteen days. We 
hypothesized that AngII-induced hypertension in WT mice would cause stiffening of aortas, which 
would be evident via a decrease in compliance of these aortas.  Our time course studies revealed 
that there is a significant increase in diameter and medial thickness of aortas at all three time points, 
however, there was no change in the compliance properties of these aortas. This suggests that 
murine aortas are capable of rapid and adaptive remodeling to compensate for the increased 
vascular strain due to elevated blood pressure. Our results showing increased pressure dependent 
diameters in AngII treated mice are in agreement with previous findings that also show that aortas 
undergo hypertrophy with AngII-induced hypertension [32, 42, 45]. We subsequently chose to 
perform our OPN KO studies at the seven-day time point because this was the earliest time point 
at which we observed pressure-dependent diameter changes.   
The next objective of this aim was to explore how the absence of OPN in aortas would 
affect aortic biomechanics. Our results show that pressure-diameter (PD) curves of OPN KO aortas 
are significantly displaced upward at baseline compared with baseline WT aortas. OPN KO aortas 
also exhibit higher compliance at mid-range pressures compared with baseline WT aortas. This 
suggests that OPN might play an important role in mediating vascular mechanics even under 
baseline conditions. These results are similar to those found in an early study that explored the role 
of OPN in vascular physiology under basal conditions. This study demonstrated that carotid 
arteries obtained from OPN KO mice exhibit greater diameters than WT mice at physiological 
pressures [171]. The study also showed that OPN KO carotids have greater elasticity at higher 
physiological pressures such as 125mm Hg and 175mm Hg [171]. We observe, however, that 
baseline OPN KO aortas demonstrate greater compliance only at mid-range, sub-physiologic 
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pressures, with the most significant difference observed at 60mm Hg. This difference in 
compliance maybe attributed to the fact that the aorta is a much larger vessel capable of reaching 
peak compliance at earlier pressures compared with the smaller carotid arteries. Aortas also have 
a very different ultrastructure as compared with carotid arteries. 
Our histological analysis reveals that OPN KO aortas have increased medial thickness at 
baseline, but this increase may be attributed to the straighter and more widely spaced elastic 
lamellae. In an intact, unloaded artery, elastin fibers typically appear undulated and wavy like 
those seen in the WT aorta (shown in the top left panel of Fig 5.11) [172]. However, as the 
transmural pressure increases, these elastin fibers straighten out as they begin to bear load, and 
continue to remain straight at physiologic pressure [172]. The arteries that were histologically 
analyzed in this study were all in the unloaded state when fixed, but it is interesting to note that 
the morphology of the elastin fibers of the baseline OPN KO aortas resemble that of a pressurized 
artery. This unique “loaded” morphology of elastin, even in the unloaded state, might suggest why 
OPN KO aortas at baseline distend significantly greater than WT aortas when pressurized. A more 
thorough evaluation of the regulation, organization, and function of other associated structural 
ECM proteins (such as collagen), and cell types such as smooth muscle cells (SMCs), needs to be 
performed for a better interpretation of these data.  
For the final objective of this aim, we tested OPN KO aortas with AngII for 7 days and 
discovered that these aortas also have significantly higher PD curves when compared with P-D 
curves of WT AngII-treated aortas. This result suggests that OPN may also be responsible for the 
mechanical distension of the aorta in the setting of hypertension. Finally, it is important to observe 
from our histological analysis that AngII treated OPN KO aortas are dramatically protected against 
adventitial thickening and inflammation which is predominant in the AngII treated WT aortas (Figs 
 
 102 
5.9, 5.11, and 5.13). A similar finding, but in the setting of neointimal formation was observed by 
Myers et al. In this study, OPN KO ligated carotid arteries showed significantly lesser neointimal 
formation than the ligated carotid arteries obtained from WT mice [171]. This study also showed 
an absence of leukocyte infiltration in histologic sections obtained from ligated carotid sections of 
OPN KO mice [171].   
While this study provides us with interesting insights on the role of OPN in mediating the 
biomechanics of the aorta, there are several limitations that need to be considered while 
interpreting these results and considered while designing future experiments. A limitation of this 
study was the lack of characterization of the axial mechanics, residual stresses and strains, and 
ECM organization of these OPN KO aortas. Conducting fixed length axial force-pressure tests, 
opening angle measurements, and a more careful analysis of ECM organization via confocal would 
shed more light on these properties of the aorta. Confocal imaging of the aorta while being 
pressurized would allow us to observe differences in the structure and organization of the ECM. 
One can take z-stack images and images of the structure of elastin and collagen, harnessing the 
auto-fluorescence properties of these proteins.  
 Another limitation of this study was our inability to capture the stress-strain properties of 
the aorta of the different treatment groups. While local compliance data provides us with some 
insight into the mechanical differences between the treatment groups, stress-strain properties 
provide a better reflection of the true mechanical properties of biologic tissues [173]. 
Circumferential vessel stress and strain are defined as follows: 
𝐶𝑖𝑟𝑐𝑢𝑚𝑓𝑒𝑟𝑒𝑛𝑡𝑖𝑎𝑙 𝑆𝑡𝑟𝑒𝑠𝑠 (𝜎𝜃) =
𝑃𝑖𝑑𝑖
ℎ
  -------[173, 174] 
where, Pi = Aortic Pressure, di = inner diameter of aorta, h = vessel wall thickness (calculated by 
subtracting inner diameter from outer diameter of the aorta) 
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𝐶𝑖𝑟𝑐𝑢𝑚𝑓𝑒𝑟𝑒𝑛𝑡𝑖𝑎𝑙 𝑆𝑡𝑟𝑎𝑖𝑛 (𝜀𝜃) =
𝑑𝑚𝑒𝑎𝑛−𝐷𝑚𝑒𝑎𝑛
𝐷𝑚𝑒𝑎𝑛
 -------[173, 174] 
where, dmean = (do + di)/2 is the mean diameter, and Dmean is the in-vivo reference configuration 
As the formulae above reflect, calculation of stress-strain properties requires measurement 
of both vessel outer-diameter and inner-diameter values, however, our device setup was only able 
to capture outer diameter and aortic pressure values. Hence, we were unable to analyze the real 
stress-strain properties of the aorta, given the lack of inner diameter data. Histological analysis 
reveals the inner diameter and medial thickness values at the unloaded configuration, therefore, 
we may use these values to approximate circumferential stress and strain values, but it is important 
to note that as transmural aortic pressure increases, the inner diameter (di) and outer diameter (do) 
increase, while the vessel wall thickness (h) decreases and this would alter the estimated 
circumferential stress values. This reduced vessel wall thickness and increased inner diameter 
would translate to overall increases in circumferential stress and strain values.    
In summary, we have shown that OPN does in fact have a significant impact on altering 
the biomechanical properties and morphology of the aorta. This was demonstrated by use of a 
transgenic OPN knockout (KO) mouse model that allowed us to delineate the specific role of OPN 
in the aorta. The combination of biomechanical data demonstrating differences in pressure-
dependent diameter and compliance parameters, and histological evidence showing differences in 
medial and adventitial thickening, and elastin organization, strongly suggest that OPN plays an 
important role in regulating the mechanical properties of the vasculature in the absence or presence 








 The primary objective of this thesis was to determine the role and regulation of osteopontin 
(OPN) in the aorta in the setting of hypertension. This was accomplished 1) through the use of an 
in-vitro model where mechanical strain was applied to aortic smooth muscle cells, 2) the use of 
two in-vivo models of murine hypertension, and 3) finally, the ex-vivo mechanical testing of OPN 
knockout (KO) aortas.  
The effects of elevated blood pressure on the cells of the aorta such as the smooth muscle 
cells are myriad and complex. Several clinical and animal studies have supported the hypothesis 
that both increased mechanical strain and humoral factors play a role in mediating inflammation 
of the aorta. However, there is still a need to isolate the potential effects of each factor in a 
controlled manner; thus in aims 1 and 2 of this project we used an in-vitro system of mechanical 
strain and two distinct in-vivo models of hypertension in order to identify how each of these factors 
independently contributed to the expression of the pro-inflammatory OPN in the aorta. In aim 2, 
we further tested whether OPN was regulated by hydrogen peroxide (H2O2) through the use of a 
transgenic mouse model that overexpresses human catalase (an enzyme that scavenges H2O2) 
specifically in smooth muscle cells. The results of our studies from aims 1 and 2 produced the 
following results: 
1) Mechanical strain, in the setting of hypertension, has a significant effect on elevating 
expression of OPN in aortic smooth muscle cells, as determined by both the in-vitro 
and in-vivo experimental tests used. 
2) The hypertension-dependent increase in OPN is regulated by hydrogen peroxide 
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Despite it being known that OPN plays an important role in mediating vascular growth and 
remodeling, especially under inflammatory conditions, there is a significant lack of data available 
on whether it directly modulates the mechanical properties of the diseased aorta. We therefore 
mechanically tested OPN knockout (KO) aortas under both healthy and hypertensive conditions 
in aim 3 of this project to clarify its potential role in the biomechanics of large arteries. The results 
of aim 3 show us that: 
1) OPN regulates pressure-dependent diameter properties and the matrix environment of 
the aorta 
2) OPN has a significant impact on the maximal compliance properties under healthy 
conditions. 
3) AngII-treated OPN KO aortas are protected against AngII-induced medial hypertrophy 
and adventitial inflammation 
Overall our results deepen our understanding of hypertension mediated vascular 
inflammation and highlight the role of OPN in altering aortic biomechanics. Taken together, these 
results have important implications in the design and development of preventative or therapeutic 




Limitations and Future Considerations 
Aim 1: Establish if mechanical strain in-vitro increases osteopontin 
The first limitation of this aim was the assumption that smooth muscle cells (SMCs) from 
all regions of the flexible membrane culture wells experience equal biaxial strains (in both the 
radial and circumferential direction) upon cyclic strain in the FlexercellTM device. However, a 
study by Vande Geest et al in which a finite element analysis was conducted to identify the 
complete strain field for the membranes of the FlexercellTM device, highlighted that the strain 
profiles of the regions of the membrane located directly above the loading post are different from 
the regions located off the post [131]. Based on the results of the biaxial simulations that were 
performed in this study, the biaxial and tangential strains for a circular region directly above the 
loading post were shown to be approximately equal, validating a state of equibiaxial strain for this 
region of the membrane. However, the region of the membrane located off the loading post was 
shown to produce large radial strains and small circumferential strains (Fig 6.1). The 
inconsistencies in the strain profile across the surface of the flexible culture membranes maybe 
one of the reasons why we failed to see an increasing cyclic strain magnitude-dependent response 
in OPN expression (Fig 3.7).  Therefore, in future mechanical strain experiments, separating cells 
located directly above the loading post from those growing off the loading post, prior to analysis, 





Figure 6.1: Different regions of the flexible membrane well experience different strain 
profiles A finite element analysis of the biaxial flexible membrane surface showed that the regions 
directly above the loading post experience large but equal magnitudes of radial and circumferential 
strains, however, the regions located off the loading post experience large radial strains and small 
circumferential strains These results suggest that cells cultured on these plates experience a range 
of strains, that may contribute to the variability in results observed when conducting cyclic strain 
experiments.  
 
The second limitation was the assumption that smooth muscle cells (SMCs) of the aorta 
experience an average cyclic strain of around 10%. There are several clinical and animal studies 
that have analyzed average aortic strains in both humans and animals, however, there is significant 
variability in the magnitudes of the aortic strain reported [119, 154, 175]. For example, a study by 
Bell et al reported that the circumferential strain experienced by the descending aorta averages 
around 12.2% (in men) to 13.7% (in women) [119]. Another study by Vogt et al showed that there 
is dramatic variability in the average circumferential strain measured across healthy aortas, from 
one subject to the next, with values ranging from as low as 6% to as high as 23% [153].  
The ascending aorta experiences longitudinal strain (along the long axis of the aorta), as a 
result of the displacement of the sino-tubular junction, during systole [176]. This longitudinal 
displacement produces negative radial strain and circumferential strain, and maybe a biomarker of 
aortic stiffness [119]. However, there are very small longitudinal strains experienced by the 
descending aorta as reported in the literature [175, 177]. 
Based on these studies, we performed a strain-dependent study to see if OPN levels would 
vary with increasing strain magnitudes. We observed the most significant increase in OPN at 10% 
  
Region Directly Above the 
Loading Post - 
Experiences large, but equal 
magnitudes of radial and 
circumferential strains 
Region Directly Off the 
Loading Post - 
Experiences large radial strains 
and small circumferential strains 
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strain. We, therefore, chose this strain magnitude for all our subsequent studies. In reality, 
however, SMCs likely experience a range of strains, depending on the region they are harvested 
from, the corresponding aortic geometry of the region, and the healthy or diseased state of the 
aorta. For future experiments, a careful in-vivo analysis of the range of strains experienced by the 
aorta, under varying conditions and at different locations of the aortic wall, prior to harvesting 
SMCs for in-vitro mechanical strain experiments, would allow us to more accurately recapitulate 
the mechanical environment sensed by these cells in-vivo.  
Finally, another limitation of this aim is the lack of clarity on the role of hydrogen peroxide 
(H2O2), in regulating the increase of OPN with mechanical strain. We conducted a study where we 
strained SMCs for 24 hours in the presence of PEG-Catalase. Media was harvested from these 
cells and an ELISA conducted to analyze secreted OPN levels, however, no significant effect of 
catalase on OPN levels was observed (Appendix, Fig A.1).  
Given this result, we analyzed PEG-Catalase activity over the course of 24 hours in media. 
It was observed that PEG-Catalase incubated at 37C for 24 hours drastically loses its activity 
within the first 6 hours of incubation (Appendix, Fig A.2). We, therefore, redesigned our 
experiment (Appendix, Fig A.3) such that SMCs would be exposed to a steady dose of active PEG-
Catalase over the entire time course of the experiment. We did this, by adding PEG-Catalase at 
regular 6 hour intervals to the SMCs that were being strained, for a total of 24 hours. However, 
the results of this experiment also did not show any significant changes in the strain-induced 
increase in OPN expression with the addition of catalase (Appendix, Fig A.4). These results 
suggest that PEG-Catalase may not be an ideal candidate for scavenging H2O2, at least in the in-
vitro setting. In future studies, a more stable method to reduce H2O2 levels within cells, via culture 
of catalase overexpressing SMCs or transient overexpression of catalase, may provide more 
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conclusive evidence regarding the role of hydrogen peroxide in strain-induced OPN expression. 
However, caution must be taken while using SMCs from transgenic smooth muscle cell specific 
catalase overexpressing mice. SMCs from mice aortas were used at the onset of this project to 
analyze their behavior in response to cyclic strain. However, we observed that SMCs do not attach 
well onto the flexible membrane culture plates, and have inconsistent responses when cyclically 
strained. On the other hand, SMCs obtained from rat aortas attached more strongly to the surface 
of the flexible membrane plates, and had consistent behavior in response to cyclic strain. 
Therefore, the species from where SMCs are obtained ought to be carefully considered and 
experimental conditions optimized prior to testing.  
Aim 2: To determine if osteopontin expression is increased in a murine model of hypertension and 
if this increase is H2O2-dependent  
The results of aim 2 demonstrated that hypertension-induced OPN expression was 
mediated by H2O2. However, a limitation of this study is that it is unclear whether this event is 
mediated by the global decrease of H2O2 within the entire aortic wall or the local decrease of H2O2 
specific to SMCs. There are studies from our lab (unpublished) that have suggested that AngII-
treated mice that overexpress catalase specifically in macrophages are protected against 
inflammation and AAA formation. This finding implicates that the global decrease in H2O2 within 
the aortic wall may be the underlying cause for the protection of the aorta against AngII-mediated 
increase in OPN. This hypothesis may be tested in the future by fluorescent staining of H2O2 within 
segments of the aorta, which would clarify whether global or local decrease in H2O2 is responsible 
for OPN reduction in the setting of AngII-induced hypertension. Co-staining aortic cross-sections 
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for OPN and H2O2 may further elucidate the underlying mechanism responsible for regulating 
OPN expression.  
A second limitation of this study was a lack of clarity on the role of superoxide in mediating 
hypertension-dependent increase of OPN. Our results from aim 1 suggest that superoxide is indeed 
upregulated in the setting of mechanical strain (Fig 3.8). It is also known from animal studies that 
hypertensive arterial tissues have higher levels of superoxide [178]. Therefore, in order to deepen 
our understanding of the range of ROS at work in the regulation of OPN, it is important in future 
studies to analyze the role of this molecule. This maybe done via pharmacologic intervention 
through the use of the superoxide scavenging enzyme, namely superoxide disumutase (SOD). As 
an alternate approach, transgenic SOD overexpressing mice or SOD KO 1 and 2 mice may also be 
used in order to explore the role of superoxide in regulating hypertension-induced OPN expression.  
Another limitation of this study is the lack of validation of the finding that H2O2 regulates 
hypertension-induced increases in OPN, using an alternative approach. While there are no reported 
changes in vascular physiology of the transgenic smooth muscle-specific overexpressing catalase 
strain of mice under baseline conditions (as characterized in [81]), it is unknown if there may be 
compensatory changes affecting other organ systems, as a result of this catalase overexpression. It 
is therefore important to validate these findings in the future using an alternative approach to 
decrease levels of H2O2 within the aorta. One technique that may be considered for future 
experiments could involve pharmacologic intervention via the continuous infusion of PEG-




Aim 3: To determine the contribution of osteopontin to the mechanical properties of the aorta at 
baseline and in the setting of hypertension. 
A limitation of our work in aim 3 is the lack of characterization of axial mechanics of the 
OPN KO aorta under healthy and hypertensive conditions. Even though our preliminary analysis 
suggested that there is no significant difference between the in-vivo length of the aortas of OPN 
KO and WT mice under baseline and hypertensive conditions, a more thorough analysis is 
necessary to clarify the role of OPN in mediating both circumferential and axial mechanics. This 
role may be clarified via axial force-length and axial force-pressure tests using the mechanical 
testing setup previously described by Gleason et al.  
A second limitation of this aim was the lack of characterization of residual strains within 
the OPN KO and WT aortas under baseline and hypertensive conditions. Opening angles of blood 
vessels can be obtained by bisecting segments of the aorta cutting which results in the stress-free 
configuration of the vessel. Opening angles are a reflection of the residual circumferential strain 
within the inner and outer wall of a blood vessel, and also reflect differences in its material and 
mechanical properties. Given that we observed differences in medial hypertrophy, adventitial 
inflammation, elastin fiber organization and collagen expression in both the OPN KO and WT 
baseline and AngII-treated groups, characterization of the opening angles in the future could 
further validate these changes that we observed.  
A third limitation of aim 3, is our interpretation or lack thereof, of the histology data 
showing altered elastin fiber organization of OPN KO aortas. Our data showed that OPN KO aortas 
at baseline have altered elastin fiber structure as compared to WT aortas. OPN KO aortas at 
baseline had elastin fibers that were straighter and exhibiting larger elastin interlamellar gaps (Fig 
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5.12-5.13), while WT aortas at baseline had elastin fibers that were wavy, undulating, and tightly 
spaced in concentric layers. It would be important in future studies to perform a more detailed 
analysis of the elastin and collagen organization of OPN KO and WT aortas. This may be done via 
confocal imaging of the aorta at different intraluminal pressures. A custom biomechanical device 
as developed by Gleason et al., that fits on an inverted confocal microscope maybe used to 
visualize the microstructure and ECM organization across the entire wall of unfixed, live OPN KO 
and WT aortas at different transmural pressures and axial stretches. Furthermore, the z-stack data 
obtained from this device would also allow for the precise calculation of the adventitial thickness 
(from collagen images) and medial thickness (from elastin images).  
There is also a lack of data in aim 3 regarding the behavior of AngII treated OPN KO or 
WT aortas at later time points (21, 28 days or more). In this study, we look at early changes (3, 7, 
or 14 days of AngII treatment) in mechanical and morphological behavior of aortas. While we do 
in fact observe changes in the pressure-dependent diameter metrics of WT and OPN KO aortas at 
these early time points, we do not observe any changes in the compliance properties of these aortas. 
The lack of change in compliance properties in WT aortas at 3, 7, or 14 days of AngII treatment 
suggests that these aortas are able to perfectly remodel and adapt to increases in blood pressure. 
Therefore, based on our results from these early time point studies, we hypothesize that arterial 
stiffness in WT mice increases only under conditions of prolonged, untreated hypertension (21 
days or longer) and that OPN KO mice are protected against this AngII-induced stiffening. Hence, 
future studies should evaluate the mechanical behavior of these OPN KO and WT aortas at later 
time points of AngII-induced hypertension. Finally, we only use a single model of hypertension to 
study the effects of OPN on the biomechanics of the aorta. In the future, it is important to utilize 
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multiple models of hypertension including norepinephrine (NE), which we have used in aim II to 
in order validate and expand our findings from this aim.  
Implications 
 
 Hypertension has a direct impact on vascular hypertrophy, and is a known risk factor for 
the development of atherosclerosis [81]. This atherogenic potential of hypertension has been 
proposed to exist, due to the pro-inflammatory state within the arterial wall, elicited by elevated 
blood pressure [2]. It is already well established in literature that one of the early changes in 
hypertension is the generation of reactive oxygen species (ROS) within the vessel wall [2, 39, 46, 
77, 80, 90, 134]. These increased ROS levels, result in the upregulation of redox-sensitive gene 
products such as MCP-1 and VCAM-1, that lead to the infiltration of leukocytes and macrophages, 
ultimately resulting in either atherosclerosis or vascular hypertrophy [49, 89, 134, 179].   The 
results of this thesis provide a novel mechanism by which this pro-inflammatory state is developed 
in the aorta, via osteopontin (OPN). Our results have shown that OPN is significantly upregulated, 
in smooth muscle cells with the application of mechanical strain, and in the aorta with elevated 
blood pressure. We have further observed that this hypertension-induced increase in OPN is 
mediated by hydrogen peroxide. Overall these results provide a novel redox-sensitive mechanism 
by which hypertension, induces inflammation within the aorta.  
 This work has also provided unique insights on the role of OPN in regulating the mechanics 
of blood vessels. In OPN knockout (KO) aortas, it was interesting to note that the pressure-
dependent diameter curves had an upward shift (or larger diameters), when compared to aortas 
expressing OPN (from WT mice), under both baseline and hypertensive conditions. Baseline OPN 
KO aortas also had a greater maximal compliance (at 60mm Hg) compared to WT aortas, 
suggesting that OPN may be playing a role in regulating mid-range pressure compliance properties 
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of blood vessels. Adventitial inflammation and vascular hypertrophy were significantly attenuated 
in hypertensive OPN KO mice compared to hypertensive WT mice. There was also a blunting in 
collagen expression in the hypertensive OPN KO aortas. Finally, our histological analysis revealed 
that OPN KO aortas had altered elastin fiber morphology compared to WT aortas at baseline 
conditions. In the future, a more detailed analysis on elastin fiber orientation and organization is 
necessary, to understand the role of OPN in the regulation of elastin morphology and function.  
These novel insights into the redox-sensitive expression of OPN and its contribution to 
arterial biomechanics, together, provides us with a clearer understanding of the progression of 
atherosclerosis in the setting of hypertension. This knowledge should be carefully considered in 
the future design of therapies and strategies aimed against the consequences of hypertension, the 
most common being atherosclerosis.  
 Finally, these findings on the redox-sensitive regulation of OPN, imply that it may 
also be upregulated via a similar signaling pathway, in the setting of the formation of aortic 
abdominal aneurysms (AAAs). There are animal studies that have already established OPN’s role 
in the formation of AAA [180]. There are studies that have also explored the association between 
OPN polymorphisms and AAA formations, however, no association was observed between the 
five single nucleotide polymorphisms or haplotypes of the OPN gene and AAA formation or aortic 
diameter [181]. However, it was shown that the serum concentration of OPN had an association 
with AAA formation. Taking these results and our studies one step further, we speculate that OPN 
may also serve as a useful biomarker not only for AAAs, but for other vascular inflammation-
related complications as well, such as AAAs or atherosclerosis.  
Previous work from our group and others, have also revealed parallel changes that occur 
in the early stages of AAA formation and hypertension-related atherosclerosis – such as significant 
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oxidative stress, increase in pro-inflammatory proteins, and infiltration of macrophages and 
leukocytes into the vessel wall. All these findings taken together reveal a critical role for 
osteopontin in mediating vascular inflammation and its consequences that range from 





  This work has provided evidence, for the first time, that osteopontin (OPN) is a 
mechanosensitive inflammatory product expressed by SMCs of the aorta. We have identified that 
OPN is upregulated with hypertension and have demonstrated a causal role of H2O2 in mediating 
this increase.  Finally, we have identified a novel role for OPN in mediating the structure and 
mechanics of the aorta under both a healthy and hypertensive context. As highlighted in this 
chapter, the findings of this work provide additional questions and render alternative directions to 
pursue, in the context of hypertension-induced vascular inflammation. These findings give us 
novel insights into the pathogenesis of inflammation and a deeper understanding of the relation 







Figure A.1: Cyclic Strain-induced Increase in OPN was not Affected with 24 hours PEG-
Catalase Treatment We measured secreted OPN expression in cells strained and treated with 
PEG-Catalase for 24 hours. We observed a significant increase in secreted OPN expression with 
24 hours of strain (black bar) compared to the non-strained control (white bar). However, no 
difference in OPN expression was observed in strained cells treated with PEG-Catalase treatment 
(U/mL)  (gray bars) for an N=6 
 
 
Figure A.2: Catalase Activity in Cell Culture Medium Drops Within 6 hours We observed 
that PEG-Catalase in Cell Culture Medium at 37C drastically loses activity within the first 6 hours 




























































Figure A.3: Updated Experimental Design to Account for Reduced Catalase Activity In order 
to account for decreased PEG-Catalase activity within 6 hours of incubation, we updated the 
experimental design to include periodic spiking of strained SMCs every 6 hours (where PEG-
Catalase would be added at the start 0h, 6h, 12h, 18h, and 22h of the test)  
 
 
Figure A.4: PEG-Catalase May Blunt Strained-induced cellular OPN at Higher 
Concentrations OPN protein levels were measured using Western Blot analysis and normalized 
to β-Actin *p<0.05, **p=<0.01, N = 3. We observed a trending decrease in OPN expression with 
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